Michael Prados, MD

Title(s)Professor, Neurological Surgery
SchoolSchool of Medicine
Address1450 Third St, #546
San Francisco CA 94158
Phone415-637-6561
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Louisiana State UniversityM.D.1974School of Medicine
    Collapse Awards and Honors
    Society of Neuro-Oncology2014Victor Levin Award for Clinical Excellence
    Society of Neuro-Oncology2003  - 2005President
    National Brain Tumor Foundation1997Clinical Excellence Award 1997
    Society of Neuro-Oncology1995  - 1997Vice-President

    Collapse Overview 
    Collapse Overview
    Michael Prados began his career in Neuro-Oncology as a Fellow at the University of California San Francisco in 1985. Following a two year training program, he was recruited to the Faculty in 1988 and has remained at UCSF since that time, and holds the Charles B Wilson Chair in Neurosurgery. His career interests center around patient care, and clinical and translational research. He became the Project Leader of the North America Brain Tumor Consortium (NABTC), an NCI-CTEP supported multi-institutional early phase clinical trials consortium, and led that group for 15 years. When the NABTC merged with the NABTT (and became the Adult Brain Tumor Consortium) he was named co-Project Leader until stepping down in early 2014. In 2009, he was awarded the Project Leadership of what is called the Ivy Foundation Early Phase Clinical Trials Consortium, a group of now 7 major academic centers who conduct clinical and translation research in adults with brain cancer. The Consortium is now led by Nicholas Butowski, MD from UCSF.

    He was the Institutional site Principal Investigator for the Pediatric Brain Tumor Consortium (PBTC) for over 10 years, ending that role in 2012. Shortly thereafter he formed the Pacific Pediatric Neuro-Oncology Consortium (PNOC), a multi-institutional consortium of now 15 major academic centers across the United States, conducing early phase, precision-focused, clinical trials in young children and adolescents. Dr. Prados retired from UCSF in October 2015, and the PNOC is now led by Sabine Mueller, MD, PhD.

    UCSF requested that Dr. Prados return on a part-time basis in January 2016 as Professor Emeritus, to devote his efforts towards pediatric Neuro-Oncology clinical and translational research. Towards that end, he is the co-Project Leader of a pediatric brain tumor SPORE project at UCSF, and is co-Project Leader of the PNOC. His academic appointments are within Neurosurgery, retaining the Charles B. Wilson endowed chair, and the Department of Pediatrics.

    His major interests are early phase clinical trials research, and the translational studies that precede and inform those trials in both adults and children. He has published over 300 articles since 1985, has been NIH/NCI funded continuously since 1994 and is part of the Editorial board of Neuro-Oncology, Journal of Neuro-Oncology and Journal of Clinical Oncology, and a member of the NCI/CTEP Brain Malignancies Steering Committee. In 2014 he was awarded the Victor Levin Award for lifetime clinical research excellence from the Society of Neuro-Oncology.
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    PNOC Clinical Trials Consortium
    Pacific Pediatric Neuro-Oncology ConsortiumJul 1, 2012 - Oct 31, 2015
    Role: Project Leader
    Ivy Foundation Early Phase Clinical Trials Consortium
    Ivy Foundation Dec 1, 2009 - Dec 31, 2016
    Role: Principal Investigator
    Adult Brain Tumor Consortium (ABTC)
    NIH U01CA137443Jan 1, 2009 - Apr 30, 2014
    Role: Co-Principal Investigator
    Novel Approaches for Improving Pediatric BRAFv600e Glioma Patient Outcomes
    NIH/NCI 2 P50 CA097257-11A1Sep 20, 2002 - Aug 31, 2018
    Role: Project Co-Leader
    Brain Tumor SPORE Grant
    NIH/NCI 2 P50 CA097257-11A1Sep 20, 2002 - Aug 31, 2018
    Role: Administrative Core D co-leader
    The Cancer Center Support Grant
    NIH/NCI P30 CA 82103-15Aug 5, 1999 - May 31, 2017
    Role: Neurological Surgery Project Leader
    PEDIATRIC BRAIN TUMOR CLINICAL TRIAL CONSORTIUM
    NIH U01CA081449Apr 1, 1999 - Mar 31, 2004
    Role: Principal Investigator
    NABTC Central Operation Grant (UCSF Project Leader)
    NIH U01CA062399Mar 25, 1994 - Dec 31, 2009
    Role: Principal Investigator
    NABTC Member Intitution Grant (UCSF Project Leader)
    NIH U01CA062422Mar 25, 1994 - Dec 31, 2009
    Role: Co-Principal Investigator
    PEDIATRIC CLINICAL RESEARCH CENTER
    NIH M01RR001271Dec 1, 1981 - Mar 31, 2007
    Role: Co-Investigator
    CLINICAL THERAPY FOR MALIGNANT BRAIN TUMORS
    NIH P01CA013525Apr 1, 1979 - Sep 30, 2000
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of BRAF V600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial. AJNR Am J Neuroradiol. 2024 Mar 07. Ramakrishnan D, Brüningk SC, von Reppert M, Memon F, Maleki N, Aneja S, Kazerooni AF, Nabavizadeh A, Lin M, Bousabarah K, Molinaro A, Nicolaides T, Prados M, Mueller S, Aboian MS. PMID: 38453411.
      View in: PubMed   Mentions:    Fields:    
    2. Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials. J Clin Oncol. 2024 Feb 23; JCO2301084. Margol AS, Molinaro AM, Onar-Thomas A, Resnick A, Hanson D, Kieran M, Mishra-Kalyani P, Rivera D, Barone A, Arons D, Meehan C, Prados M. PMID: 38394473.
      View in: PubMed   Mentions:    Fields:    
    3. Rational combination platform trial design for children and young adults with Diffuse Midline Glioma: a report from PNOC. Neuro Oncol. 2023 Dec 20. Mueller S, Kline C, Franson A, van der Lugt J, Prados M, Waszak SM, Plasschaert S, Molinaro AM, Koschmann C, Nazarian J. PMID: 38124481.
      View in: PubMed   Mentions:    Fields:    
    4. Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. J Clin Oncol. 2024 Feb 01; 42(4):441-451. Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, Abdelbaki MS, Goldman S, Elster JD, Kraya A, Lueder MR, Ramakrishnan D, von Reppert M, Liu KX, Rokita JL, Resnick AC, Solomon DA, Phillips JJ, Prados M, Molinaro AM, Waszak SM, Mueller S. PMID: 37978951; PMCID: PMC10824388.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    5. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma. J Clin Oncol. 2023 Nov 10; 41(32):4945-4952. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. PMID: 37935104.
      View in: PubMed   Mentions: 1     Fields:    
    6. PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol. 2023 11 02; 25(11):2074-2086. Mueller S, Kline C, Stoller S, Lundy S, Christopher L, Reddy AT, Banerjee A, Cooney TM, Raber S, Hoffman C, Luks T, Wembacher-Schroeder E, Lummel N, Zhang Y, Bonner ER, Nazarian J, Molinaro AM, Prados M, Villanueva-Meyer JE, Gupta N. PMID: 37318058; PMCID: PMC10628948.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    7. Current Strategies for Management of Medulloblastoma. Diagnostics (Basel). 2023 Aug 08; 13(16). Prados MD. PMID: 37627881; PMCID: PMC10453892.
      View in: PubMed   Mentions:
    8. Applying collaborative brain power to pull us out of the dark ages of pediatric neuro-oncology. Neoplasia. 2023 07; 41:100905. Koschmann C, Prados M. PMID: 37149933; PMCID: PMC10193223.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Evaluating preclinical evidence for clinical translation in childhood brain tumours: Guidelines from the CONNECT, PNOC, and ITCC brain networks. Front Oncol. 2023; 13:1167082. Jones C, Straathof K, Fouladi M, Hargrave D, Prados M, Resnick A, Doz F, Jones DTW, Mueller S. PMID: 37091147; PMCID: PMC10114612.
      View in: PubMed   Mentions:
    10. mRNA aggregates harness danger response for potent cancer immunotherapy. medRxiv. 2023 Mar 17. Mendez-Gomez HR, DeVries A, Castillo P, Stover BD, Qdaisat S, Von Roemeling C, Ogando-Rivas E, Weidert F, McGuiness J, Zhang D, Chung MC, Li D, Zhang C, Marconi C, Campaneria Y, Chardon-Robles J, Grippin A, Karachi A, Thomas N, Huang J, Milner R, Sahay B, Sawyer WG, Ligon JA, Silver N, Simon E, Cleaver B, Wynne K, Hodik M, Molinaro A, Guan J, Kellish P, Doty A, Lee JH, Carrera-Justiz S, Rahman M, Gatica S, Mueller S, Prados M, Ghiaseddin A, Mitchell DA, Sayour EJ. PMID: 36993772; PMCID: PMC10055442.
      View in: PubMed   Mentions:
    11. Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad027. Fathi Kazerooni A, Arif S, Madhogarhia R, Khalili N, Haldar D, Bagheri S, Familiar AM, Anderson H, Haldar S, Tu W, Chul Kim M, Viswanathan K, Muller S, Prados M, Kline C, Vidal L, Aboian M, Storm PB, Resnick AC, Ware JB, Vossough A, Davatzikos C, Nabavizadeh A. PMID: 37051331; PMCID: PMC10084501.
      View in: PubMed   Mentions: 6  
    12. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Sci Transl Med. 2023 01 11; 15(678):eabm6863. Budhraja KK, McDonald BR, Stephens MD, Contente-Cuomo T, Markus H, Farooq M, Favaro PF, Connor S, Byron SA, Egan JB, Ernst B, McDaniel TK, Sekulic A, Tran NL, Prados MD, Borad MJ, Berens ME, Pockaj BA, LoRusso PM, Bryce A, Trent JM, Murtaza M. PMID: 36630480; PMCID: PMC10080578.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    13. Automated Tumor Segmentation and Brain Tissue Extraction from Multiparametric MRI of Pediatric Brain Tumors: A Multi-Institutional Study. medRxiv. 2023 Jan 11. Kazerooni AF, Arif S, Madhogarhia R, Khalili N, Haldar D, Bagheri S, Familiar AM, Anderson H, Haldar S, Tu W, Kim MC, Viswanathan K, Muller S, Prados M, Kline C, Vidal L, Aboian M, Storm PB, Resnick AC, Ware JB, Vossough A, Davatzikos C, Nabavizadeh A. PMID: 36711966; PMCID: PMC9882407.
      View in: PubMed   Mentions:
    14. ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449. J Neurooncol. 2023 Jan; 161(1):33-43. Sloan AE, Nock CJ, Ye X, Buerki R, Chang S, Lesser G, Norden A, Cloughesy T, Olson J, Kerstetter-Fogle A, Rich J, Fisher J, Desideri S, Takebe N, Timmer W, Grossman S, Prados M. PMID: 36581779.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. Neoplasia. 2023 01; 35:100846. Lilly JV, Rokita JL, Mason JL, Patton T, Stefankiewiz S, Higgins D, Trooskin G, Larouci CA, Arya K, Appert E, Heath AP, Zhu Y, Brown MA, Zhang B, Farrow BK, Robins S, Morgan AM, Nguyen TQ, Frenkel E, Lehmann K, Drake E, Sullivan C, Plisiewicz A, Coleman N, Patterson L, Koptyra M, Helili Z, Van Kuren N, Young N, Kim MC, Friedman C, Lubneuski A, Blackden C, Williams M, Baubet V, Tauhid L, Galanaugh J, Boucher K, Ijaz H, Cole KA, Choudhari N, Santi M, Moulder RW, Waller J, Rife W, Diskin SJ, Mateos M, Parsons DW, Pollack IF, Goldman S, Leary S, Caporalini C, Buccoliero AM, Scagnet M, Haussler D, Hanson D, Firestein R, Cain J, Phillips JJ, Gupta N, Mueller S, Grant G, Monje-Deisseroth M, Partap S, Greenfield JP, Hashizume R, Smith A, Zhu S, Johnston JM, Fangusaro JR, Miller M, Wood MD, Gardner S, Carter CL, Prolo LM, Pisapia J, Pehlivan K, Franson A, Niazi T, Rubin J, Abdelbaki M, Ziegler DS, Lindsay HB, Stucklin AG, Gerber N, Vaske OM, Quinsey C, Rood BR, Nazarian J, Raabe E, Jackson EM, Stapleton S, Lober RM, Kram DE, Koschmann C, Storm PB, Lulla RR, Prados M, Resnick AC, Waanders AJ. PMID: 36335802; PMCID: PMC9641002.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    16. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. Clin Cancer Res. 2022 09 15; 28(18):3965-3978. Kline C, Jain P, Kilburn L, Bonner ER, Gupta N, Crawford JR, Banerjee A, Packer RJ, Villanueva-Meyer J, Luks T, Zhang Y, Kambhampati M, Zhang J, Yadavilli S, Zhang B, Gaonkar KS, Rokita JL, Kraya A, Kuhn J, Liang W, Byron S, Berens M, Molinaro A, Prados M, Resnick A, Waszak SM, Nazarian J, Mueller S. PMID: 35852795.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    17. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. J Clin Invest. 2022 06 15; 132(12). Mueller S, Taitt JM, Villanueva-Meyer JE, Bonner ER, Nejo T, Lulla RR, Goldman S, Banerjee A, Chi SN, Whipple NS, Crawford JR, Gauvain K, Nazemi KJ, Watchmaker PB, Almeida ND, Okada K, Salazar AM, Gilbert RD, Nazarian J, Molinaro AM, Butterfield LH, Prados MD, Okada H. PMID: 35703183; PMCID: PMC9203080.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma. J Neurooncol. 2021 Jul; 153(3):447-454. Bush NAO, Young JS, Zhang Y, Dalle Ore CL, Molinaro AM, Taylor J, Clarke J, Prados M, Braunstein SE, Raleigh DR, Chang SM, Berger MS, Butowski NA. PMID: 34125374; PMCID: PMC8279971.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    19. BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort. Oncology. 2021; 99(9):580-588. Vassilakopoulou M, Won M, Curran WJ, Souhami L, Prados MD, Langer CJ, Rimm DL, Hanna JA, Neumeister VM, Melian E, Diaz AZ, Atkins JN, Komarnicky LT, Schultz CJ, Howard SP, Zhang P, Dicker AP, Knisely JPS. PMID: 33957633; PMCID: PMC8491475.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. J Clin Invest. 2020 12 01; 130(12):6325-6337. Mueller S, Taitt JM, Villanueva-Meyer JE, Bonner ER, Nejo T, Lulla RR, Goldman S, Banerjee A, Chi SN, Whipple NS, Crawford JR, Gauvain K, Nazemi KJ, Watchmaker PB, Almeida ND, Okada K, Salazar AM, Gilbert RD, Nazarian J, Molinaro AM, Butterfield LH, Prados MD, Okada H. PMID: 32817593; PMCID: PMC7685729.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCellsCTClinical Trials
    21. Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa124. Chen H, Kuhn J, Lamborn KR, Abrey LE, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WKA, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Wen PY, Gilbert MR. PMID: 33235994; PMCID: PMC7668489.
      View in: PubMed   Mentions: 5  
    22. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 2020 06; 21(6):e317-e329. Erker C, Tamrazi B, Poussaint TY, Mueller S, Mata-Mbemba D, Franceschi E, Brandes AA, Rao A, Haworth KB, Wen PY, Goldman S, Vezina G, MacDonald TJ, Dunkel IJ, Morgan PS, Jaspan T, Prados MD, Warren KE. PMID: 32502458.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    23. Population Pharmacokinetics of Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E-Mutant Astrocytomas. J Clin Pharmacol. 2020 09; 60(9):1209-1219. Wang H, Long-Boyle J, Winger BA, Nicolaides T, Mueller S, Prados M, Ivaturi V. PMID: 32476174.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    24. Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002). Oncotarget. 2020 May 26; 11(21):1942-1952. Nicolaides T, Nazemi KJ, Crawford J, Kilburn L, Minturn J, Gajjar A, Gauvain K, Leary S, Dhall G, Aboian M, Robinson G, Long-Boyle J, Wang H, Molinaro AM, Mueller S, Prados M. PMID: 32523649; PMCID: PMC7260122.
      View in: PubMed   Mentions: 30     Fields:    
    25. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol. 2020 04 01; 6(4):495-503. Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, Zhang Y, Phillips JJ, Shai A, Lafontaine M, Crane J, Chandra A, Flanigan P, Jahangiri A, Cioffi G, Ostrom Q, Anderson JE, Badve C, Barnholtz-Sloan J, Sloan AE, Erickson BJ, Decker PA, Kosel ML, LaChance D, Eckel-Passow J, Jenkins R, Villanueva-Meyer J, Rice T, Wrensch M, Wiencke JK, Oberheim Bush NA, Taylor J, Butowski N, Prados M, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Berger MS. PMID: 32027343; PMCID: PMC7042822.
      View in: PubMed   Mentions: 177     Fields:    Translation:HumansCells
    26. Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas. PLoS One. 2019; 14(12):e0219724. Berens ME, Sood A, Barnholtz-Sloan JS, Graf JF, Cho S, Kim S, Kiefer J, Byron SA, Halperin RF, Nasser S, Adkins J, Cuyugan L, Devine K, Ostrom Q, Couce M, Wolansky L, McDonough E, Schyberg S, Dinn S, Sloan AE, Prados M, Phillips JJ, Nelson SJ, Liang WS, Al-Kofahi Y, Rusu M, Zavodszky MI, Ginty F. PMID: 31881020; PMCID: PMC6934292.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    27. Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma. Neurooncol Pract. 2020 Jan; 7(1):4-10. Cooney T, Yeo KK, Kline C, Prados M, Haas-Kogan D, Chi S, Mueller S. PMID: 32257279; PMCID: PMC7104878.
      View in: PubMed   Mentions: 9  
    28. Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM. Mol Cancer Ther. 2019 09; 18(9):1565-1576. McKinney A, Lindberg OR, Engler JR, Chen KY, Kumar A, Gong H, Lu KV, Simonds EF, Cloughesy TF, Liau LM, Prados M, Bollen AW, Berger MS, Shieh JTC, James CD, Nicolaides TP, Yong WH, Lai A, Hegi ME, Weiss WA, Phillips JJ. PMID: 31270152; PMCID: PMC6726545.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    29. A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium. Int J Cancer. 2019 10 01; 145(7):1889-1901. Mueller S, Jain P, Liang WS, Kilburn L, Kline C, Gupta N, Panditharatna E, Magge SN, Zhang B, Zhu Y, Crawford JR, Banerjee A, Nazemi K, Packer RJ, Petritsch CK, Truffaux N, Roos A, Nasser S, Phillips JJ, Solomon D, Molinaro A, Waanders AJ, Byron SA, Berens ME, Kuhn J, Nazarian J, Prados M, Resnick AC. PMID: 30861105.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCTClinical Trials
    30. Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. J Clin Oncol. 2019 03 20; 37(9):741-750. Wen PY, Touat M, Alexander BM, Mellinghoff IK, Ramkissoon S, McCluskey CS, Pelton K, Haidar S, Basu SS, Gaffey SC, Brown LE, Martinez-Ledesma JE, Wu S, Kim J, Wei W, Park MA, Huse JT, Kuhn JG, Rinne ML, Colman H, Agar NYR, Omuro AM, DeAngelis LM, Gilbert MR, de Groot JF, Cloughesy TF, Chi AS, Roberts TM, Zhao JJ, Lee EQ, Nayak L, Heath JR, Horky LL, Batchelor TT, Beroukhim R, Chang SM, Ligon AH, Dunn IF, Koul D, Young GS, Prados MD, Reardon DA, Yung WKA, Ligon KL. PMID: 30715997; PMCID: PMC6553812.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCellsCTClinical Trials
    31. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Clin Cancer Res. 2018 12 01; 24(23):5850-5859. Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, Gupta N, Myseros JS, Hwang EI, Kline C, Crawford JR, Warren KE, Cha S, Liang WS, Berens ME, Packer RJ, Resnick AC, Prados M, Mueller S, Nazarian J. PMID: 30322880; PMCID: PMC6279526.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansPHPublic Health
    32. Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol. 2018 10 09; 20(11):1547-1555. Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, Fangusaro J, Goldman S, Tomita T, Alden T, DiPatri A, Rubin JB, Gauvain K, Limbrick D, Leonard J, Geyer JR, Leary S, Browd S, Wang Z, Sood S, Bendel A, Nagib M, Gardner S, Karajannis MA, Harter D, Ayyanar K, Gump W, Bowers DC, Weprin B, MacDonald TJ, Aguilera D, Brahma B, Robison NJ, Kiehna E, Krieger M, Sandler E, Aldana P, Khatib Z, Ragheb J, Bhatia S, Mueller S, Banerjee A, Bredlau AL, Gururangan S, Fuchs H, Cohen KJ, Jallo G, Dorris K, Handler M, Comito M, Dias M, Nazemi K, Baird L, Murray J, Lindeman N, Hornick JL, Malkin H, Sinai C, Greenspan L, Wright KD, Prados M, Bandopadhayay P, Ligon KL, Kieran MW. PMID: 29741745; PMCID: PMC6176802.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    33. Attitudes toward fertility and fertility preservation in women with glioma. Neurooncol Pract. 2019 May; 6(3):218-225. Stiner RK, Clarke JL, Sinha N, Chan J, Letourneau JM, Niemasik EE, Rabbitt JE, Chang SM, Butowski NA, Prados MD, Rosen MP. PMID: 31386027; PMCID: PMC6656302.
      View in: PubMed   Mentions: 4  
    34. Using genomics to guide treatment for glioblastoma. Pharmacogenomics. 2018 10; 19(15):1217-1229. Young JS, Prados MD, Butowski N. PMID: 30203716.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    35. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Neuro Oncol. 2018 09 03; 20(10):1411-1418. Ellingson BM, Aftab DT, Schwab GM, Hessel C, Harris RJ, Woodworth DC, Leu K, Chakhoyan A, Raymond C, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Holland J, Ping J, Weitzman R, Wen PY, Cloughesy TF. PMID: 29660005; PMCID: PMC6120362.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    36. Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma. J Neurooncol. 2018 Nov; 140(2):477-483. Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M. PMID: 30151703; PMCID: PMC6239922.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    37. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2018 08 02; 20(9):1240-1250. Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF. PMID: 29660006; PMCID: PMC6071654.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    38. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02. Neuro Oncol. 2018 03 27; 20(4):546-556. Galanis E, Anderson SK, Miller CR, Sarkaria JN, Jaeckle K, Buckner JC, Ligon KL, Ballman KV, Moore DF, Nebozhyn M, Loboda A, Schiff D, Ahluwalia MS, Lee EQ, Gerstner ER, Lesser GJ, Prados M, Grossman SA, Cerhan J, Giannini C, Wen PY, Alliance for Clinical Trials in Oncology and ABTC. PMID: 29016887; PMCID: PMC5909661.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCTClinical Trials
    39. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy. Neuro Oncol. 2018 01 22; 20(2):249-258. Wen PY, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Holland J, Ping J, Weitzman R, Cloughesy TF. PMID: 29016998; PMCID: PMC5777496.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    40. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy. Neuro Oncol. 2018 01 22; 20(2):259-267. Cloughesy TF, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Ping J, Holland J, Weitzman R, Wen PY. PMID: 29036345; PMCID: PMC5777491.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    41. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol. 2018 01 10; 20(1):13-23. Warren KE, Vezina G, Poussaint TY, Warmuth-Metz M, Chamberlain MC, Packer RJ, Brandes AA, Reiss M, Goldman S, Fisher MJ, Pollack IF, Prados MD, Wen PY, Chang SM, Dufour C, Zurakowski D, Kortmann RD, Kieran MW. PMID: 28449033; PMCID: PMC5761545.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    42. Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma. Clin Cancer Res. 2018 01 15; 24(2):295-305. Byron SA, Tran NL, Halperin RF, Phillips JJ, Kuhn JG, de Groot JF, Colman H, Ligon KL, Wen PY, Cloughesy TF, Mellinghoff IK, Butowski NA, Taylor JW, Clarke JL, Chang SM, Berger MS, Molinaro AM, Maggiora GM, Peng S, Nasser S, Liang WS, Trent JM, Berens ME, Carpten JD, Craig DW, Prados MD. PMID: 29074604; PMCID: PMC7516926.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    43. Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02. J Neurooncol. 2018 Jan; 136(1):79-86. Nghiemphu PL, Ebiana VA, Wen P, Gilbert M, Abrey LE, Lieberman F, DeAngelis LM, Robins HI, Yung WKA, Chang S, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados M, Kuhn J, Cloughesy TF. PMID: 28988377; PMCID: PMC5756101.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    44. A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro Oncol. 2017 Aug 01; 19(8):1135-1144. Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S, Pollack IF, Goldman S, Doyle LA, Stewart CF, Boyett JM, Kun LE, Fouladi M. PMID: 28339824; PMCID: PMC5570236.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCTClinical Trials
    45. Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas. Cancer. 2017 Dec 01; 123(23):4631-4639. Wahl M, Chang SM, Phillips JJ, Molinaro AM, Costello JF, Mazor T, Alexandrescu S, Lupo JM, Nelson SJ, Berger M, Prados M, Taylor JW, Butowski N, Clarke JL, Haas-Kogan D. PMID: 28759109; PMCID: PMC5693663.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    46. Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy. J Neurooncol. 2017 Jun; 133(2):257-264. Ulasov IV, Foster H, Butters M, Yoon JG, Ozawa T, Nicolaides T, Figueroa X, Hothi P, Prados M, Butters J, Cobbs C. PMID: 28434113.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    47. A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma. Cancer Chemother Pharmacol. 2017 03; 79(3):603-610. Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD. PMID: 28233053.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    48. Clinical trial endpoints for patients with gliomas. Neurooncol Pract. 2017 Dec; 4(4):201-208. Taylor JW, Molinaro AM, Butowski N, Prados M. PMID: 31385993; PMCID: PMC6655446.
      View in: PubMed   Mentions: 5  
    49. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide. Neuro Oncol. 2017 02 01; 19(2):242-251. Wahl M, Phillips JJ, Molinaro AM, Lin Y, Perry A, Haas-Kogan DA, Costello JF, Dayal M, Butowski N, Clarke JL, Prados M, Nelson S, Berger MS, Chang SM. PMID: 27571885; PMCID: PMC5464133.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    50. Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas. J Neurooncol. 2017 03; 132(1):181-188. Nayak L, de Groot J, Wefel JS, Cloughesy TF, Lieberman F, Chang SM, Omuro A, Drappatz J, Batchelor TT, DeAngelis LM, Gilbert MR, Aldape KD, Yung AW, Fisher J, Ye X, Chen A, Grossman S, Prados M, Wen PY. PMID: 28116649; PMCID: PMC5588922.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    51. Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas. Oncotarget. 2017 Jan 03; 8(1):583-595. Yao TW, Zhang J, Prados M, Weiss WA, James CD, Nicolaides T. PMID: 27611946; PMCID: PMC5352180.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    52. Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas. J Neurooncol. 2017 02; 131(3):495-505. Zhang J, Yao TW, Hashizume R, Hariono S, Barkovich KJ, Fan QW, Prados M, James CD, Weiss WA, Nicolaides T. PMID: 27848137; PMCID: PMC5560871.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    53. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. J Neurooncol. 2016 10; 130(1):171-179. Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. PMID: 27535746; PMCID: PMC5069332.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    54. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth. Neuro Oncol. 2016 11; 18(11):1519-1528. Hashizume R, Zhang A, Mueller S, Prados MD, Lulla RR, Goldman S, Saratsis AM, Mazar AP, Stegh AH, Cheng SY, Horbinski C, Haas-Kogan DA, Sarkaria JN, Waldman T, James CD. PMID: 27370397; PMCID: PMC5063519.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    55. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. J Clin Oncol. 2016 07 20; 34(21):2468-77. Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, Lipp ES, Dunham C, Hukin J, Eisenstat DD, Fulton D, van Landeghem FK, Santi M, van Veelen ML, Van Meir EG, Osuka S, Fan X, Muraszko KM, Tirapelli DP, Oba-Shinjo SM, Marie SK, Carlotti CG, Lee JY, Rao AA, Giannini C, Faria CC, Nunes S, Mora J, Hamilton RL, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L, Zollo M, Cinalli G, Bognár L, Klekner A, Hortobágyi T, Leary S, Ermoian RP, Olson JM, Leonard JR, Gardner C, Grajkowska WA, Chambless LB, Cain J, Eberhart CG, Ahsan S, Massimino M, Giangaspero F, Buttarelli FR, Packer RJ, Emery L, Yong WH, Soto H, Liau LM, Everson R, Grossbach A, Shalaby T, Grotzer M, Karajannis MA, Zagzag D, Wheeler H, von Hoff K, Alonso MM, Tuñon T, Schüller U, Zitterbart K, Sterba J, Chan JA, Guzman M, Elbabaa SK, Colman H, Dhall G, Fisher PG, Fouladi M, Gajjar A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K, Lieberman F, Mikkelsen T, Omuro AM, Pollack IF, Prados M, Robins HI, Soffietti R, Wu J, Metellus P, Tabori U, Bartels U, Bouffet E, Hawkins CE, Rutka JT, Dirks P, Pfister SM, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Ellison DW, Taylor MD. PMID: 27269943; PMCID: PMC4962737.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    56. Biopsy for diffuse intrinsic pontine glioma: a reappraisal. J Neurosurg Pediatr. 2016 Sep; 18(3):390-1. Kieran MW, Goumnerova LC, Prados M, Gupta N. PMID: 27153377.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    57. Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma. J Neurooncol. 2016 Feb; 126(3):395. Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA. PMID: 26782702.
      View in: PubMed   Mentions: 1     Fields:    
    58. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol. 2016 Jan; 126(1):193-200. Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N, Weinberg VK, Tihan T, Barnes M, Mueller S, Butowski NA, Clarke JL, Chang SM, McDermott MM, Prados MD, Berger MS, Haas-Kogan DA. PMID: 26493740; PMCID: PMC4826306.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    59. Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk. Oncotarget. 2015 Dec 15; 6(40):42468-77. Walsh KM, Codd V, Rice T, Nelson CP, Smirnov IV, McCoy LS, Hansen HM, Elhauge E, Ojha J, Francis SS, Madsen NR, Bracci PM, Pico AR, Molinaro AM, Tihan T, Berger MS, Chang SM, Prados MD, Jenkins RB, Wiemels JL, Wiemels JL, ENGAGE Consortium Telomere Group, Samani NJ, Wiencke JK, Wrensch MR. PMID: 26646793; PMCID: PMC4767445.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    60. Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials. Transl Oncol. 2015 Dec; 8(6):446-55. Wen Q, Jalilian L, Lupo JM, Li Y, Roy R, Molinaro AM, Chang SM, Prados M, Butowski N, Clarke J, Nelson SJ. PMID: 26692525; PMCID: PMC4700297.
      View in: PubMed   Mentions: 1  
    61. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro Oncol. 2016 Apr; 18(4):557-64. Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A, Huse J, Phillips J, West BL, Nolop KB, Hsu HH, Ligon KL, Molinaro AM, Prados M. PMID: 26449250; PMCID: PMC4799682.
      View in: PubMed   Mentions: 282     Fields:    Translation:HumansCTClinical Trials
    62. Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma. J Neurooncol. 2016 Feb; 126(3):385-93. Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA. PMID: 26384810; PMCID: PMC4907264.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    63. EGFR blockade prevents glioma escape from BRAFV600E targeted therapy. Oncotarget. 2015 Sep 08; 6(26):21993-2005. Yao TW, Zhang J, Prados M, Weiss WA, James CD, Nicolaides T. PMID: 26023796; PMCID: PMC4673141.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    64. Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors. J Clin Oncol. 2015 Oct 01; 33(28):3186-92. Gounder MM, Nayak L, Sahebjam S, Muzikansky A, Sanchez AJ, Desideri S, Ye X, Ivy SP, Nabors LB, Prados M, Grossman S, DeAngelis LM, Wen PY. PMID: 26282642; PMCID: PMC4857195.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    65. Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence. Neurosurgery. 2015 Aug; 62 Suppl 1:160-5. Han SJ, Englot DJ, Birk H, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA. PMID: 26181937; PMCID: PMC5260825.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    66. The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma. Neurosurgery. 2015 Aug; 77(2):248-53; discussion 253. Han SJ, Rutledge WC, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA. PMID: 25856113; PMCID: PMC4506198.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    67. Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. J Clin Oncol. 2015 Aug 20; 33(24):2646-54. Robinson GW, Orr BA, Wu G, Gururangan S, Lin T, Qaddoumi I, Packer RJ, Goldman S, Prados MD, Desjardins A, Chintagumpala M, Takebe N, Kaste SC, Rusch M, Allen SJ, Onar-Thomas A, Stewart CF, Fouladi M, Boyett JM, Gilbertson RJ, Curran T, Ellison DW, Gajjar A. PMID: 26169613; PMCID: PMC4534527.
      View in: PubMed   Mentions: 193     Fields:    Translation:HumansCTClinical Trials
    68. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015 Jun 25; 372(26):2499-508. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O'Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB. PMID: 26061753; PMCID: PMC4489704.
      View in: PubMed   Mentions: 956     Fields:    Translation:HumansCells
    69. Toward precision medicine in glioblastoma: the promise and the challenges. Neuro Oncol. 2015 Aug; 17(8):1051-63. Prados MD, Byron SA, Tran NL, Phillips JJ, Molinaro AM, Ligon KL, Wen PY, Kuhn JG, Mellinghoff IK, de Groot JF, Colman H, Cloughesy TF, Chang SM, Ryken TC, Tembe WD, Kiefer JA, Berens ME, Craig DW, Carpten JD, Trent JM. PMID: 25934816; PMCID: PMC4490873.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    70. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab. J Neurooncol. 2015 Jan; 121(2):331-9. Wen Q, Jalilian L, Lupo JM, Molinaro AM, Chang SM, Clarke J, Prados M, Nelson SJ. PMID: 25351579; PMCID: PMC4311062.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    71. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). Neuro Oncol. 2014 Oct; 16 Suppl 7:vii36-47. Wen PY, Cloughesy TF, Ellingson BM, Reardon DA, Fine HA, Abrey L, Ballman K, Bendszuz M, Buckner J, Chang SM, Prados MD, Pope WB, Gregory Sorensen A, van den Bent M, Yung WK. PMID: 25313237; PMCID: PMC4195530.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    72. Familial gliomas: cases in two pairs of brothers. J Neurooncol. 2015 Jan; 121(1):135-40. Osorio JA, Hervey-Jumper SL, Walsh KM, Clarke JL, Butowski NA, Prados MD, Berger MS. PMID: 25208478.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group. Neuro Oncol. 2015 Feb; 17(2):180-8. Alexander BM, Galanis E, Yung WK, Ballman KV, Boyett JM, Cloughesy TF, Degroot JF, Huse JT, Mann B, Mason W, Mellinghoff IK, Mikkelsen T, Mischel PS, O'Neill BP, Prados MD, Sarkaria JN, Tawab-Amiri A, Trippa L, Ye X, Ligon KL, Berry DA, Wen PY. PMID: 25165194; PMCID: PMC4288520.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    74. Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Neuro Oncol. 2015 Mar; 17(3):440-7. Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, Necesito-Reyes MJ, Colman H, Dhall G, Lieberman FS, Metellus P, Mikkelsen T, Omuro A, Partap S, Prados M, Robins HI, Soffietti R, Wu J, Gilbert MR, Armstrong TS, CERN Foundation. PMID: 25121770; PMCID: PMC4483095.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    75. A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma. Neuro Oncol. 2014 Jul; 16(7):984-90. Clarke JL, Molinaro AM, Phillips JJ, Butowski NA, Chang SM, Perry A, Costello JF, DeSilva AA, Rabbitt JE, Prados MD. PMID: 24637230; PMCID: PMC4057142.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    76. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014 Jul; 46(7):731-5. Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Pekmezci M, Zheng S, Wiemels JL, Wiemels JL, Pico AR, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, O'Neill BP, Sicotte H, Eckel-Passow JE, ENGAGE Consortium Telomere Group, van der Harst P, Wiencke JK, Samani NJ, Jenkins RB, Wrensch MR. PMID: 24908248; PMCID: PMC4074274.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCells
    77. Plexiform neurofibromas, trial design, and the definitions of "progression" and "treatment failure". Neuro Oncol. 2014 May; 16(5):617-8. Prados MD. PMID: 24714524; PMCID: PMC3984566.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    78. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet. 2014 May; 46(5):462-6. Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO, Bechet D, Faury D, De Jay N, Ramkissoon LA, Corcoran A, Jones DT, Sturm D, Johann P, Tomita T, Goldman S, Nagib M, Bendel A, Goumnerova L, Bowers DC, Leonard JR, Rubin JB, Alden T, Browd S, Geyer JR, Leary S, Jallo G, Cohen K, Gupta N, Prados MD, Carret AS, Ellezam B, Crevier L, Klekner A, Bognar L, Hauser P, Garami M, Myseros J, Dong Z, Siegel PM, Malkin H, Ligon AH, Albrecht S, Pfister SM, Ligon KL, Majewski J, Jabado N, Kieran MW. PMID: 24705250; PMCID: PMC4282994.
      View in: PubMed   Mentions: 230     Fields:    Translation:HumansAnimalsCells
    79. "We will know it when we see it;" bevacizumab and glioblastoma. Neuro Oncol. 2014 Apr; 16(4):469-70. Prados MD. PMID: 24637548; PMCID: PMC3956364.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma. Neuro Oncol. 2014 Sep; 16(9):1255-62. Han SJ, Rolston JD, Molinaro AM, Clarke JL, Prados MD, Chang SM, Berger MS, DeSilva A, Butowski NA. PMID: 24670608; PMCID: PMC4136897.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    81. Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02. Neuro Oncol. 2014 Apr; 16(4):567-78. Wen PY, Chang SM, Lamborn KR, Kuhn JG, Norden AD, Cloughesy TF, Robins HI, Lieberman FS, Gilbert MR, Mehta MP, Drappatz J, Groves MD, Santagata S, Ligon AH, Yung WK, Wright JJ, Dancey J, Aldape KD, Prados MD, Ligon KL. PMID: 24470557; PMCID: PMC3956354.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCTClinical Trials
    82. Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol. 2014 Jan; 16(2):274-9. Bloch O, Crane CA, Fuks Y, Kaur R, Aghi MK, Berger MS, Butowski NA, Chang SM, Clarke JL, McDermott MW, Prados MD, Sloan AE, Bruce JN, Parsa AT. PMID: 24335700; PMCID: PMC3895386.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    83. Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro Oncol. 2014 Mar; 16(3):352-60. Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow AK, Phillips J, Smirnov I, Tom MW, Prados MD, James CD, Berger MS, Gupta N, Haas-Kogan DA. PMID: 24305702; PMCID: PMC3922515.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    84. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10; 155(2):462-77. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O'Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, TCGA Research Network. PMID: 24120142; PMCID: PMC3910500.
      View in: PubMed   Mentions: 2546     Fields:    Translation:HumansCells
    85. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis. Neuro Oncol. 2013 Aug; 15(8):1041-7. Walsh KM, Rice T, Decker PA, Kosel ML, Kollmeyer T, Hansen HM, Zheng S, McCoy LS, Bracci PM, Anderson E, Hsuang G, Wiemels JL, Pico AR, Smirnov I, Molinaro AM, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, Sicotte H, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR. PMID: 23733245; PMCID: PMC3714154.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    86. Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children. Childs Nerv Syst. 2013 Aug; 29(8):1313-9. Cage TA, Samagh SP, Mueller S, Nicolaides T, Haas-Kogan D, Prados M, Banerjee A, Auguste KI, Gupta N. PMID: 23666401.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    87. Gliosarcoma arising from an oligodendroglioma (oligosarcoma). Clin Neuropathol. 2013 May-Jun; 32(3):165-70. Hiniker A, Hagenkord JM, Powers MP, Aghi MK, Prados MD, Perry A. PMID: 23254140.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    88. Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer. 2013 Sep; 60(9):1397-401. Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW. PMID: 23625747; PMCID: PMC6300142.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    89. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol. 2013 Sep; 23(5):584-94. Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R, Gajjar A, Goldman S, Lehman NL, Metellus P, Mikkelsen T, Necesito-Reyes MJ, Omuro A, Packer RJ, Partap S, Pollack IF, Prados MD, Robins HI, Soffietti R, Wu J, Miller CR, Gilbert MR, Aldape KD, Collaborative Ependymoma Research Network. PMID: 23452038; PMCID: PMC8028973.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    90. Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report. J Neurosurg. 2013 Jun; 118(6):1220-3. Cage TA, Pekmezci M, Prados M, Berger MS. PMID: 23421452.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    91. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro Oncol. 2013 May; 15(5):535-41. Rice T, Zheng S, Decker PA, Walsh KM, Bracci P, Xiao Y, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Hsuang G, Wiemels JL, Tihan T, Pico AR, Prados MD, Chang SM, Berger MS, Caron A, Fink S, Kollmeyer T, Rynearson A, Voss J, Kosel ML, Fridley BL, Lachance DH, Eckel-Passow JE, Sicotte H, O'Neill BP, Giannini C, Wiencke JK, Jenkins RB, Wrensch MR. PMID: 23361564; PMCID: PMC3635511.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    92. Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept. Target Oncol. 2013 Jun; 8(2):117-25. Shonka N, Piao Y, Gilbert M, Yung A, Chang S, DeAngelis LM, Lassman AB, Liu J, Cloughesy T, Robins HI, Lloyd R, Chen A, Prados M, Wen PY, Heymach J, de Groot J. PMID: 23345034; PMCID: PMC4802008.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    93. Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study. Nefrologia. 2013; 33(2):196-203. Dolores Arenas M, Pérez-García R, Bennouna M, Blanco A, Mauricio O, Prados MD, Lerma JL, Luisa Muñiz M, Belén Martín M, Estudio COMQUELFOS. PMID: 23364580.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    94. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts. Neuro Oncol. 2013 Feb; 15(2):189-97. Chen PY, Ozawa T, Drummond DC, Kalra A, Fitzgerald JB, Kirpotin DB, Wei KC, Butowski N, Prados MD, Berger MS, Forsayeth JR, Bankiewicz K, James CD. PMID: 23262509; PMCID: PMC3548589.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    95. Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. Neuro Oncol. 2012 Dec; 14(12):1511-8. Lee EQ, Kuhn J, Lamborn KR, Abrey L, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WK, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Gilbert MR, Wen PY. PMID: 23099651; PMCID: PMC3499017.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    96. Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment. J Neurooncol. 2012 Dec; 110(3):305-13. Hashizume R, Smirnov I, Liu S, Phillips JJ, Hyer J, McKnight TR, Wendland M, Prados M, Banerjee A, Nicolaides T, Mueller S, James CD, Gupta N. PMID: 22983601.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    97. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet. 2012 Oct; 44(10):1122-5. Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM, Kosel ML, Zheng S, Walsh KM, Rice T, Bracci P, McCoy LS, Smirnov I, Patoka JS, Hsuang G, Wiemels JL, Tihan T, Pico AR, Prados MD, Chang SM, Berger MS, Caron AA, Fink SR, Halder C, Rynearson AL, Fridley BL, Buckner JC, O'Neill BP, Giannini C, Lachance DH, Wiencke JK, Eckel-Passow JE, Wrensch MR. PMID: 22922872; PMCID: PMC3600846.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    98. Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03. Clin Cancer Res. 2012 Nov 01; 18(21):6032-9. Lee EQ, Puduvalli VK, Reid JM, Kuhn JG, Lamborn KR, Cloughesy TF, Chang SM, Drappatz J, Yung WK, Gilbert MR, Robins HI, Lieberman FS, Lassman AB, McGovern RM, Xu J, Desideri S, Ye X, Ames MM, Espinoza-Delgado I, Prados MD, Wen PY. PMID: 22923449; PMCID: PMC3947570.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    99. Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein. Clin Cancer Res. 2013 Jan 01; 19(1):205-14. Crane CA, Han SJ, Ahn B, Oehlke J, Kivett V, Fedoroff A, Butowski N, Chang SM, Clarke J, Berger MS, McDermott MW, Prados MD, Parsa AT. PMID: 22872572.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCellsCTClinical Trials
    100. Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leuk Lymphoma. 2013 Jan; 54(1):58-61. Nayak L, Abrey LE, Drappatz J, Gilbert MR, Reardon DA, Wen PY, Prados M, Deangelis LM, Omuro A, North American Brain Tumor Consortium. PMID: 22656234; PMCID: PMC4802006.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    101. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome. Neuro Oncol. 2012 Sep; 14(9):1146-52. Mueller S, Phillips J, Onar-Thomas A, Romero E, Zheng S, Wiencke JK, McBride SM, Cowdrey C, Prados MD, Weiss WA, Berger MS, Gupta N, Haas-Kogan DA. PMID: 22753230; PMCID: PMC3424210.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    102. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol. 2012 Jul 20; 30(21):2641-7. Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR, Lazarus KH, Packer RJ, Prados M, Sposto R, Vezina G, Wisoff JH, Pollack IF. PMID: 22665535; PMCID: PMC3413276.
      View in: PubMed   Mentions: 152     Fields:    Translation:Humans
    103. SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res. 2012 Jun 01; 18(11):3154-62. Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, O'Neill BP, Buckner JC, Thompson RC, Nabors LB, Olson JJ, Brem S, Madden MH, Browning JE, Wiencke JK, Egan KM, Jenkins RB, Wrensch MR. PMID: 22472174; PMCID: PMC3607457.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    104. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov. 2012 May; 2(5):458-71. Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, Pedraza A, Brennan CW, Heguy A, Liau LM, Lieberman F, Yung WK, Gilbert MR, Reardon DA, Drappatz J, Wen PY, Lamborn KR, Chang SM, Prados MD, Fine HA, Horvath S, Wu N, Lassman AB, DeAngelis LM, Yong WH, Kuhn JG, Mischel PS, Mehta MP, Cloughesy TF, Mellinghoff IK. PMID: 22588883; PMCID: PMC3354723.
      View in: PubMed   Mentions: 195     Fields:    Translation:HumansAnimalsCells
    105. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol. 2012 07; 108(3):491-8. Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Lada P, Prados M, Goldin J, Wen PY, Cloughesy T. PMID: 22426926; PMCID: PMC3997502.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    106. Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients. Cancer Chemother Pharmacol. 2012 Jun; 69(6):1507-18. Reardon DA, Conrad CA, Cloughesy T, Prados MD, Friedman HS, Aldape KD, Mischel P, Xia J, DiLea C, Huang J, Mietlowski W, Dugan M, Chen W, Yung WK. PMID: 22392572; PMCID: PMC4351868.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    107. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol. 2012 May; 123(5):727-38. Wani K, Armstrong TS, Vera-Bolanos E, Raghunathan A, Ellison D, Gilbertson R, Vaillant B, Goldman S, Packer RJ, Fouladi M, Pollack I, Mikkelsen T, Prados M, Omuro A, Soffietti R, Ledoux A, Wilson C, Long L, Gilbert MR, Aldape K, Collaborative Ependymoma Research Network. PMID: 22322993; PMCID: PMC4013829.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    108. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery. 2012 Feb; 70(2):361-70. Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL, McDermott MW, Parsa AT, Berger MS, Aghi MK. PMID: 21841523.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    109. An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neurooncol. 2012 May; 108(1):29-35. Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD, Gupta N. PMID: 22231932; PMCID: PMC3841009.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    110. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype. J Neuropathol Exp Neurol. 2012 Jan; 71(1):83-9. Goldhoff P, Clarke J, Smirnov I, Berger MS, Prados MD, James CD, Perry A, Phillips JJ. PMID: 22157621; PMCID: PMC3246124.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    111. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol. 2011 Dec 01; 29(34):4482-90. Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS. PMID: 22025148; PMCID: PMC3236649.
      View in: PubMed   Mentions: 235     Fields:    Translation:HumansCells
    112. Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol. 2011 Nov 01; 29(31):4175-80. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M. PMID: 21969507; PMCID: PMC3208537.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    113. Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts. Neuro Oncol. 2011 Dec; 13(12):1288-95. Serwer LP, Noble CO, Michaud K, Drummond DC, Kirpotin DB, Ozawa T, Prados MD, Park JW, James CD. PMID: 21954443; PMCID: PMC3223095.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    114. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov. 2011 Oct; 1(5):442-56. Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, Kuga D, Amzajerdi AN, Soto H, Zhu S, Babic I, Tanaka K, Dang J, Iwanami A, Gini B, Dejesus J, Lisiero DD, Huang TT, Prins RM, Wen PY, Robins HI, Prados MD, Deangelis LM, Mellinghoff IK, Mehta MP, James CD, Chakravarti A, Cloughesy TF, Tontonoz P, Mischel PS. PMID: 22059152; PMCID: PMC3207317.
      View in: PubMed   Mentions: 222     Fields:    Translation:HumansAnimalsCells
    115. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol. 2011 Dec; 13(12):1331-8. Butowski N, Chang SM, Lamborn KR, Polley MY, Pieper R, Costello JF, Vandenberg S, Parvataneni R, Nicole A, Sneed PK, Clarke J, Hsieh E, Costa BM, Reis RM, Hristova-Kazmierski M, Nicol SJ, Thornton DE, Prados MD. PMID: 21896554; PMCID: PMC3223090.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCellsCTClinical Trials
    116. Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. J Neurooncol. 2012 Jan; 106(2):367-75. Pejavar S, Polley MY, Rosenberg-Wohl S, Chennupati S, Prados MD, Berger MS, Banerjee A, Gupta N, Haas-Kogan D. PMID: 21826561.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    117. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol. 2011 Oct; 13(10):1118-24. Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Lamborn KR, Prados MD, North American Brain Tumor Consortium. PMID: 21813511; PMCID: PMC3177665.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    118. It is time to include patients with brain tumors in phase I trials in oncology. J Clin Oncol. 2011 Aug 20; 29(24):3211-3. Wen PY, Schiff D, Cloughesy TF, Reardon DA, Batchelor TT, Chabner BA, Flaherty K, de Groot JF, Gilbert MR, Galanis E, Chang SM, Schwartz GK, Peereboom D, Mehta MP, Yung WK, Grossman SA, Prados MD, DeAngelis LM. PMID: 21768451; PMCID: PMC4836609.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    119. Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol. 2012 Jan; 106(1):147-53. Gilbert MR, Kuhn J, Lamborn KR, Lieberman F, Wen PY, Mehta M, Cloughesy T, Lassman AB, Deangelis LM, Chang S, Prados M. PMID: 21739168; PMCID: PMC4351869.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    120. Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clin Cancer Res. 2011 Jul 15; 17(14):4872-81. de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, DeAngelis L, Camphausen K, Chen A, Yung WK, Prados M, Wen PY, Heymach JV. PMID: 21632852; PMCID: PMC3139700.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    121. Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol. 2011 Jul 01; 29(19):2689-95. de Groot JF, Lamborn KR, Chang SM, Gilbert MR, Cloughesy TF, Aldape K, Yao J, Jackson EF, Lieberman F, Robins HI, Mehta MP, Lassman AB, Deangelis LM, Yung WK, Chen A, Prados MD, Wen PY. PMID: 21606416; PMCID: PMC3139373.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCTClinical Trials
    122. Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jun; 13(6):660-8. Wefel JS, Cloughesy T, Zazzali JL, Zheng M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS. PMID: 21558074; PMCID: PMC3107095.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    123. A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro Oncol. 2011 May; 13(5):509-16. Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Yung WK, Gilbert MR, Chang SM, Lieberman FS, Prados MD, Fine HA. PMID: 21377994; PMCID: PMC3093337.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    124. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression. Neuro Oncol. 2011 Mar; 13(3):280-9. Zheng S, Houseman EA, Morrison Z, Wrensch MR, Patoka JS, Ramos C, Haas-Kogan DA, McBride S, Marsit CJ, Christensen BC, Nelson HH, Stokoe D, Wiemels JL, Wiemels JL, Chang SM, Prados MD, Tihan T, Vandenberg SR, Kelsey KT, Berger MS, Wiencke JK. PMID: 21339190; PMCID: PMC3064601.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    125. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. Neuro Oncol. 2011 Mar; 13(3):298-306. Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE. PMID: 21339191; PMCID: PMC3064607.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    126. The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. Clin Cancer Res. 2011 Apr 01; 17(7):2014-23. Leng S, Bernauer AM, Hong C, Do KC, Yingling CM, Flores KG, Tessema M, Tellez CS, Willink RP, Burki EA, Picchi MA, Stidley CA, Prados MD, Costello JF, Gilliland FD, Crowell RE, Belinsky SA. PMID: 21355081; PMCID: PMC3070839.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    127. Identifying the needs of brain tumor patients and their caregivers. J Neurooncol. 2011 Sep; 104(3):737-44. Parvataneni R, Polley MY, Freeman T, Lamborn K, Prados M, Butowski N, Liu R, Clarke J, Page M, Rabbitt J, Fedoroff A, Clow E, Hsieh E, Kivett V, Deboer R, Chang S. PMID: 21311950; PMCID: PMC3170122.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    128. Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide. Neuro Oncol. 2011 Apr; 13(4):384-92. Prasad G, Sottero T, Yang X, Mueller S, James CD, Weiss WA, Polley MY, Ozawa T, Berger MS, Aftab DT, Prados MD, Haas-Kogan DA. PMID: 21317208; PMCID: PMC3064692.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansAnimalsCells
    129. Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg. 2011 Jun; 114(6):1609-16. Clark AJ, Butowski NA, Chang SM, Prados MD, Clarke J, Polley MY, Sughrue ME, McDermott MW, Parsa AT, Berger MS, Aghi MK. PMID: 21142749.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    130. Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Oncologist. 2010; 15(12):1329-34. Vredenburgh JJ, Cloughesy T, Samant M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Das A, Friedman HS. PMID: 21147867; PMCID: PMC3227925.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    131. Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jan; 13(1):143-51. Prados M, Cloughesy T, Samant M, Fang L, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS. PMID: 21084434; PMCID: PMC3018914.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    132. A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1422-7. Nghiemphu PL, Wen PY, Lamborn KR, Drappatz J, Robins HI, Fink K, Malkin MG, Lieberman FS, DeAngelis LM, Torres-Trejo A, Chang SM, Abrey L, Fine HA, Demopoulos A, Lassman AB, Kesari S, Mehta MP, Prados MD, Cloughesy TF, North American Brain Tumor Consortium. PMID: 20934264; PMCID: PMC3020272.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    133. Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis. 2010 Oct; 31(10):1770-7. Schwartzbaum JA, Xiao Y, Liu Y, Tsavachidis S, Berger MS, Bondy ML, Chang JS, Chang SM, Decker PA, Ding B, Hepworth SJ, Houlston RS, Hosking FJ, Jenkins RB, Kosel ML, McCoy LS, McKinney PA, Muir K, Patoka JS, Prados M, Rice T, Robertson LB, Schoemaker MJ, Shete S, Swerdlow AJ, Wiemels JL, Wiencke JK, Yang P, Wrensch MR. PMID: 20668009; PMCID: PMC2950934.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    134. Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study. Neuro Oncol. 2010 Oct; 12(10):1061-70. Yung WK, Vredenburgh JJ, Cloughesy TF, Nghiemphu P, Klencke B, Gilbert MR, Reardon DA, Prados MD. PMID: 20615922; PMCID: PMC3018931.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    135. Brain tumors: from childhood through adolescence into adulthood. J Clin Oncol. 2010 Nov 10; 28(32):4783-9. Kieran MW, Walker D, Frappaz D, Prados M. PMID: 20458039.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    136. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010 Apr 13; 17(4):362-75. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, Lamszus K, Westphal M, Heim S, James CD, VandenBerg SR, Costello JF, Moorefield S, Cowdrey CJ, Prados M, Phillips HS. PMID: 20385361.
      View in: PubMed   Mentions: 277     Fields:    Translation:HumansCells
    137. Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts. Cancer Res. 2010 Apr 15; 70(8):3228-38. Michaud K, Solomon DA, Oermann E, Kim JS, Zhong WZ, Prados MD, Ozawa T, James CD, Waldman T. PMID: 20354191; PMCID: PMC2855904.
      View in: PubMed   Mentions: 199     Fields:    Translation:HumansAnimalsCells
    138. Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol. 2010 Oct; 100(1):121-7. Mishra KK, Squire S, Lamborn K, Banerjee A, Gupta N, Wara WM, Prados MD, Berger MS, Haas-Kogan DA. PMID: 20221671; PMCID: PMC2951507.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    139. Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). Neuro Oncol. 2010 Aug; 12(8):855-61. Iwamoto FM, Lamborn KR, Robins HI, Mehta MP, Chang SM, Butowski NA, Deangelis LM, Abrey LE, Zhang WT, Prados MD, Fine HA. PMID: 20200024; PMCID: PMC2940686.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCTClinical Trials
    140. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer. 2010 Mar 01; 116(5):1358-66. Han SJ, Yang I, Ahn BJ, Otero JJ, Tihan T, McDermott MW, Berger MS, Prados MD, Parsa AT. PMID: 20052717.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    141. Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study. Neuro Oncol. 2010 Jun; 12(6):608-13. Butowski N, Chang SM, Lamborn KR, Polley MY, Parvataneni R, Hristova-Kazmierski M, Musib L, Nicol SJ, Thornton DE, Prados MD. PMID: 20156802; PMCID: PMC2940647.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    142. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol. 2010 Aug; 12(8):871-81. Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK, PRECISE Study Group. PMID: 20511192; PMCID: PMC2940677.
      View in: PubMed   Mentions: 214     Fields:    Translation:HumansCTClinical Trials
    143. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing. Neuro Oncol. 2010 Apr; 12(4):366-76. Hashizume R, Gupta N, Berger MS, Banerjee A, Prados MD, Ayers-Ringler J, James CD, VandenBerg SR. PMID: 20308314; PMCID: PMC2940601.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    144. Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma. Neuro Oncol. 2010 Feb; 12(2):164-72. Wu W, Lamborn KR, Buckner JC, Novotny PJ, Chang SM, O'Fallon JR, Jaeckle KA, Prados MD. PMID: 20150383; PMCID: PMC2940570.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    145. Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide. Neuro Oncol. 2010 Mar; 12(3):274-82. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M. PMID: 20167815; PMCID: PMC2940590.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    146. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal. 2009 Dec 15; 2(101):ra82. Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB, Zhu S, Kofman AA, Bensinger SJ, Yong WH, Vinters HV, Horvath S, Watson AD, Kuhn JG, Robins HI, Mehta MP, Wen PY, DeAngelis LM, Prados MD, Mellinghoff IK, Cloughesy TF, Mischel PS. PMID: 20009104; PMCID: PMC2978002.
      View in: PubMed   Mentions: 195     Fields:    Translation:HumansCells
    147. A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro Oncol. 2010 Jan; 12(1):87-94. Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KD, Wen PY, Fine HA, Mehta M, Deangelis LM, Lieberman F, Cloughesy TF, Robins HI, Dancey J, Prados MD, North American Brain Tumor Consortium. PMID: 20150371; PMCID: PMC2940559.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    148. A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro Oncol. 2010 Jan; 12(1):95-103. Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KA, Wen PY, Fine HA, Mehta M, Deangelis LM, Lieberman F, Cloughesy TF, Robins HI, Dancey J, Prados MD, North American Brain Tumor Consortium. PMID: 20150372; PMCID: PMC2940554.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCTClinical Trials
    149. Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro Oncol. 2009 Dec; 11(6):853-60. Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD. PMID: 19293394; PMCID: PMC2802405.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCTClinical Trials
    150. High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol. 2010 May; 98(1):117-23. Nicolaides T, Tihan T, Horn B, Biegel J, Prados M, Banerjee A. PMID: 19936623; PMCID: PMC2880232.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    151. Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients. J Support Oncol. 2009 Nov-Dec; 7(6):W23-W31. Mobed K, Liu R, Stewart S, Wrensch M, McCoy L, Rice T, Prados M, Chang S. PMID: 26692824; PMCID: PMC4675625.
      View in: PubMed   Mentions: 2     Fields:    
    152. Recurrent asymptomatic demyelinating disease following 13-cis-retinoic acid exposure. BMJ Case Rep. 2009; 2009. Okuda DT, Prados MD. PMID: 21901115; PMCID: PMC3029989.
      View in: PubMed   Mentions: 1     Fields:    
    153. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009 Oct 01; 27(28):4733-40. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. PMID: 19720927.
      View in: PubMed   Mentions: 1141     Fields:    Translation:HumansCTClinical Trials
    154. Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival. J Neurooncol. 2010 Mar; 97(1):33-40. McBride SM, Perez DA, Polley MY, Vandenberg SR, Smith JS, Zheng S, Lamborn KR, Wiencke JK, Chang SM, Prados MD, Berger MS, Stokoe D, Haas-Kogan DA. PMID: 19705067; PMCID: PMC2814032.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    155. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer. 2009 Aug 01; 125(3):680-7. Wiemels JL, Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, Schwartzbaum J, Heimberger A, Sampson JH, Chang S, Prados M, Wiencke JK, Wrensch M. PMID: 19408307; PMCID: PMC2861569.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    156. Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol. 2010 Feb; 96(3):313-20. Han SJ, Yang I, Tihan T, Prados MD, Parsa AT. PMID: 19618114; PMCID: PMC2808523.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    157. A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol. 2010 Jan; 96(2):151-9. Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, Gupta N. PMID: 19585223; PMCID: PMC2808534.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    158. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009 Aug; 41(8):905-8. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, Kollmeyer TM, Kosel ML, LaChance DH, McCoy L, O'Neill BP, Patoka J, Pico AR, Prados M, Quesenberry C, Rice T, Rynearson AL, Smirnov I, Tihan T, Wiemels J, Yang P, Wiencke JK. PMID: 19578366; PMCID: PMC2923561.
      View in: PubMed   Mentions: 304     Fields:    Translation:HumansCells
    159. Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol. 2010 Jan; 96(2):211-7. Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, Yung WK, Gilbert MR, Fine HA, Mehta M, Deangelis LM, Cloughesy TF, Robins HI, Aldape K, Dancey J, Prados MD, Lieberman F, Wen PY. PMID: 19562255; PMCID: PMC3786190.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCTClinical Trials
    160. Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis. J Neurosurg Spine. 2009 Jun; 10(6):557-63. Guppy KH, Akins PT, Moes GS, Prados MD. PMID: 19558288.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    161. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol. 2009 May; 92(3):401-15. Chang SM, Nelson S, Vandenberg S, Cha S, Prados M, Butowski N, McDermott M, Parsa AT, Aghi M, Clarke J, Berger M. PMID: 19357966; PMCID: PMC2834319.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    162. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931). Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1006-11. Allen J, Donahue B, Mehta M, Miller DC, Rorke LB, Jakacki R, Robertson P, Sposto R, Holmes E, Vezina G, Muraszko K, Puccetti D, Prados M, Chan KW. PMID: 19356859; PMCID: PMC2739055.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    163. p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts. Cancer Res. 2008 Dec 15; 68(24):10034-9. Dinca EB, Lu KV, Sarkaria JN, Pieper RO, Prados MD, Haas-Kogan DA, Vandenberg SR, Berger MS, James CD. PMID: 19074867; PMCID: PMC2987557.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    164. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol. 2009 Feb 01; 27(4):579-84. Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, Fedoroff A, Sneed PK, Berger MS, McDermott MW, Parsa AT, Vandenberg S, James CD, Lamborn KR, Stokoe D, Haas-Kogan DA. PMID: 19075262; PMCID: PMC2645859.
      View in: PubMed   Mentions: 168     Fields:    Translation:HumansCTClinical Trials
    165. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg. 2008 Nov; 109(5):817-24. Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM. PMID: 18976070.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    166. A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas. J Neurooncol. 2009 Jan; 91(2):183-9. Butowski N, Lamborn KR, Lee BL, Prados MD, Cloughesy T, DeAngelis LM, Abrey L, Fink K, Lieberman F, Mehta M, Ian Robins H, Junck L, Salazar AM, Chang SM. PMID: 18850068; PMCID: PMC3104130.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    167. A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05). J Neurooncol. 2009 Jan; 91(2):175-82. Butowski N, Chang SM, Junck L, DeAngelis LM, Abrey L, Fink K, Cloughesy T, Lamborn KR, Salazar AM, Prados MD. PMID: 18797818; PMCID: PMC4779120.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCTClinical Trials
    168. In reference to lamborn et Al. (Neuro-oncology. 2008;10:162-170). Neuro Oncol. 2008 Dec; 10(6):1171-2. Meyers CA, Lamborn KR, Prados MD. PMID: 18725461; PMCID: PMC2719004.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    169. Quality of life in low-grade glioma patients receiving temozolomide. Neuro Oncol. 2009 Feb; 11(1):59-68. Liu R, Solheim K, Polley MY, Lamborn KR, Page M, Fedoroff A, Rabbitt J, Butowski N, Prados M, Chang SM. PMID: 18713953; PMCID: PMC2718960.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    170. Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium. Neuro Oncol. 2008 Aug; 10(4):631-42. Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Wen PY, Fine HA, Mehta MP, DeAngelis LM, Lieberman FS, Cloughesy TF, Robins HI, Abrey LE, Prados MD, North American Brain Tumor Consortium. PMID: 18559968; PMCID: PMC2666238.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    171. A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood. Neuro Oncol. 2008 Aug; 10(4):569-76. Jakacki RI, Yates A, Blaney SM, Zhou T, Timmerman R, Ingle AM, Flom L, Prados MD, Adamson PC, Pollack IF. PMID: 18497327; PMCID: PMC2666230.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    172. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1319-23. McBride SM, Daganzo SM, Banerjee A, Gupta N, Lamborn KR, Prados MD, Berger MS, Wara WM, Haas-Kogan DA. PMID: 18485615.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    173. Central nervous system cancers. J Natl Compr Canc Netw. 2008 May; 6(5):456-504. Brem SS, Bierman PJ, Black P, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Glass J, Grossman SA, Heimberger AB, Junck L, Linette GP, Loeffler JJ, Maor MH, Moots P, Mrugala M, Nabors LB, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Shrieve DC, Sills AK. PMID: 18492461.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    174. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma. Neuro Oncol. 2008 Jun; 10(3):341-7. Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE. PMID: 18417739; PMCID: PMC2563056.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    175. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008 Mar 10; 26(8):1338-45. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS. PMID: 18323558.
      View in: PubMed   Mentions: 383     Fields:    Translation:Humans
    176. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro Oncol. 2008 Apr; 10(2):162-70. Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD, North American Brain Tumor Consortium. PMID: 18356283; PMCID: PMC2613818.
      View in: PubMed   Mentions: 228     Fields:    Translation:Humans
    177. Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clin Cancer Res. 2007 Dec 15; 13(24):7401-6. Kuhn JG, Chang SM, Wen PY, Cloughesy TF, Greenberg H, Schiff D, Conrad C, Fink KL, Robins HI, Mehta M, DeAngelis L, Raizer J, Hess K, Lamborn KR, Dancey J, Prados MD, North American Brain Tumor Consortium and the National Cancer Institute. PMID: 18094423; PMCID: PMC4918812.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    178. Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study. Clin Cancer Res. 2007 Dec 01; 13(23):7133-8. Loghin ME, Prados MD, Wen P, Junck L, Lieberman F, Fine H, Fink KL, Metha M, Kuhn J, Lamborn K, Chang SM, Cloughesy T, DeAngelis LM, Robins IH, Aldape KD, Yung WK. PMID: 18056194; PMCID: PMC4802002.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    179. Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study. Cancer Chemother Pharmacol. 2008 May; 61(6):1059-67. Prados MD, Yung WK, Wen PY, Junck L, Cloughesy T, Fink K, Chang S, Robins HI, Dancey J, Kuhn J. PMID: 17694310; PMCID: PMC3873156.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    180. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol. 2007 Jun 01; 25(16):2288-94. Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, Barker FG, Buckner JC, James CD, Aldape K. PMID: 17538175.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    181. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2007 Nov 01; 69(3):825-30. Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott MW, Berger MS, Larson DA. PMID: 17512132.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    182. Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. J Neurooncol. 2007 Oct; 85(1):87-94. Butowski N, Lamborn KR, Berger MS, Prados MD, Chang SM. PMID: 17457513.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    183. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol. 2007 Mar 01; 25(7):837-44. Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK, Cintredekin Besudotox Intraparenchymal Study Group. PMID: 17327604.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCTClinical Trials
    184. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol. 2007 Apr 10; 25(11):1350-6. Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O'Brien J, Haqq C, Shuman M. PMID: 17312328.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCTClinical Trials
    185. Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin Cancer Res. 2007 Jan 01; 13(1):197-205. Wrensch M, McMillan A, Wiencke J, Wiemels J, Kelsey K, Patoka J, Jones H, Carlton V, Miike R, Sison J, Moghadassi M, Prados M. PMID: 17200355.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    186. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. J Neurooncol. 2007 Feb; 81(3):271-7. Groves MD, Puduvalli VK, Chang SM, Conrad CA, Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen PY, Greenberg H, Abrey LE, DeAngelis LM, Hess KR, Lamborn KR, Prados MD, Yung WK. PMID: 17031561.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    187. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clin Cancer Res. 2006 Aug 15; 12(16):4899-907. Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, Fine HA, Mehta M, Robins HI, DeAngelis LM, Groves MD, Puduvalli VK, Levin V, Conrad C, Maher EA, Aldape K, Hayes M, Letvak L, Egorin MJ, Capdeville R, Kaplan R, Murgo AJ, Stiles C, Prados MD. PMID: 16914578.
      View in: PubMed   Mentions: 157     Fields:    Translation:HumansCTClinical Trials
    188. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol. 2006 Aug 01; 24(22):3651-6. Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, Yung WK, Aldape K, Wright J, Lamborn KR, Prados MD. PMID: 16877733.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    189. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res. 2006 Jul 01; 12(13):3935-41. Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, Fuller GN, Aldape KD. PMID: 16818690.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells
    190. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies. Neurosurg Focus. 2006 Apr 15; 20(4):E15. Kunwar S, Chang SM, Prados MD, Berger MS, Sampson JH, Croteau D, Sherman JW, Grahn AY, Shu VS, Dul JL, Husain SR, Joshi BH, Pedain C, Puri RK. PMID: 16709020.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    191. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006 Apr 15; 66(8):4531-41. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR, Parsa AT, Sison JD, Prados MD. PMID: 16618782.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    192. A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol. 2006 Apr; 8(2):189-93. Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M, Fine HA, Wen PY, Cloughesy T, Chang S, Nicholas MK, Schiff D, Greenberg H, Junck L, Fink K, Hess K, Kuhn J, North American Brain Tumor Consortium. PMID: 16533878; PMCID: PMC1871932.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    193. The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Neuro Oncol. 2006 Apr; 8(2):166-74. Mishra KK, Puri DR, Missett BT, Lamborn KR, Prados MD, Berger MS, Banerjee A, Gupta N, Wara WM, Haas-Kogan DA. PMID: 16495375; PMCID: PMC1871938.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    194. Gene expression and angiotropism in primary CNS lymphoma. Blood. 2006 May 01; 107(9):3716-23. Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, Treseler P, Berger M, McDermott M, Prados M, Karch J, Okada C, Hyun W, Parikh S, Haqq C, Shuman M. PMID: 16418334; PMCID: PMC1895776.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    195. Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro Oncol. 2006 Jan; 8(1):67-78. Prados MD, Lamborn KR, Chang S, Burton E, Butowski N, Malec M, Kapadia A, Rabbitt J, Page MS, Fedoroff A, Xie D, Kelley SK. PMID: 16443950; PMCID: PMC1871925.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCTClinical Trials
    196. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro Oncol. 2006 Jan; 8(1):12-26. Wrensch M, Rice T, Miike R, McMillan A, Lamborn KR, Aldape K, Prados MD. PMID: 16443944; PMCID: PMC1871921.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    197. Management of a sporadic malignant subfrontal peripheral nerve sheath tumor. J Neurooncol. 2006 Jan; 76(2):165-9. Sanchez-Mejia RO, Pham DN, Prados M, Tihan T, Cha S, El-Sayed I, McDermott MW. PMID: 16132491.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    198. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med. 2005 Nov 10; 353(19):2012-24. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, Beroukhim R, Peck TC, Lee JC, Sellers WR, Stokoe D, Prados M, Cloughesy TF, Sawyers CL, Mischel PS. PMID: 16282176.
      View in: PubMed   Mentions: 598     Fields:    Translation:HumansCells
    199. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin Cancer Res. 2005 Nov 01; 11(21):7841-50. Lassman AB, Rossi MR, Raizer JJ, Razier JR, Abrey LE, Lieberman FS, Grefe CN, Lamborn K, Pao W, Shih AH, Kuhn JG, Wilson R, Nowak NJ, Cowell JK, DeAngelis LM, Wen P, Gilbert MR, Chang S, Yung WA, Prados M, Holland EC. PMID: 16278407.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCellsCTClinical Trials
    200. Biomarkers to predict response to epidermal growth factor receptor inhibitors. Cell Cycle. 2005 Oct; 4(10):1369-72. Haas-Kogan DA, Prados MD, Lamborn KR, Tihan T, Berger MS, Stokoe D. PMID: 16177570.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    201. Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. J Clin Oncol. 2005 Sep 20; 23(27):6647-56. Cloughesy TF, Kuhn J, Robins HI, Abrey L, Wen P, Fink K, Lieberman FS, Mehta M, Chang S, Yung A, DeAngelis L, Schiff D, Junck L, Groves M, Paquette S, Wright J, Lamborn K, Sebti SM, Prados M. PMID: 16170172.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    202. Central nervous system cancers: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2005 Sep; 3(5):644-90. Brem SS, Bierman PJ, Black P, Blumenthal DT, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Fine HA, Friedman A, Glass J, Grossman SA, Heimberger AB, Junck L, Levin V, Loeffler JJ, Maor MH, Narayana A, Newton HB, Olivi A, Portnow J, Prados M, Raizer JJ, Rosenfeld SS, Shrieve DC, Sills AK, Spence AM, Vrionis FD, National Comprehensive Cancer Network. PMID: 16194456.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    203. Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs. 2005 Aug; 23(4):357-61. Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, De Angelis L, Raizer J, Hess K, Aldape K, Lamborn KR, Kuhn J, Dancey J, Prados MD, North American Brain Tumor Consortium and the National Cancer Institute. PMID: 16012795.
      View in: PubMed   Mentions: 154     Fields:    Translation:HumansCTClinical Trials
    204. High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol. 2005 Jul; 7(3):254-9. Gomez DR, Missett BT, Wara WM, Lamborn KR, Prados MD, Chang S, Berger MS, Haas-Kogan DA. PMID: 16053700; PMCID: PMC1871913.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    205. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst. 2005 Jun 15; 97(12):880-7. Haas-Kogan DA, Prados MD, Tihan T, Eberhard DA, Jelluma N, Arvold ND, Baumber R, Lamborn KR, Kapadia A, Malec M, Berger MS, Stokoe D. PMID: 15956649.
      View in: PubMed   Mentions: 181     Fields:    Translation:HumansCellsCTClinical Trials
    206. Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg. 2005 Apr; 102(4):622-8. Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM. PMID: 15871503.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    207. Brain metastases of breast cancer. Expert Rev Anticancer Ther. 2005 Apr; 5(2):253-68. Melisko ME, Kunwar S, Prados M, Berger MS, Park JW. PMID: 15877523.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    208. A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma. Int J Radiat Oncol Biol Phys. 2005 Apr 01; 61(5):1454-9. Butowski N, Prados MD, Lamborn KR, Larson DA, Sneed PK, Wara WM, Malec M, Rabbitt J, Page M, Chang SM. PMID: 15817350.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    209. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2005 Feb; 26(2):266-73. Cha S, Tihan T, Crawford F, Fischbein NJ, Chang S, Bollen A, Nelson SJ, Prados M, Berger MS, Dillon WP. PMID: 15709123; PMCID: PMC7974081.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    210. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg. 2005 Feb; 102(2):267-75. Parney IF, Kunwar S, McDermott M, Berger M, Prados M, Cha S, Croteau D, Puri RK, Chang SM. PMID: 15739554.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    211. Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). J Clin Oncol. 2005 Jan 20; 23(3):525-31. Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman R. PMID: 15659498.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    212. Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life. Cancer Invest. 2005; 23(2):138-44. Macdonald DR, Kiebert G, Prados M, Yung A, Olson J. PMID: 15813507.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    213. Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. J Clin Oncol. 2004 Nov 01; 22(21):4282-9. Puduvalli VK, Yung WK, Hess KR, Kuhn JG, Groves MD, Levin VA, Zwiebel J, Chang SM, Cloughesy TF, Junck L, Wen P, Lieberman F, Conrad CA, Gilbert MR, Meyers CA, Liu V, Mehta MP, Nicholas MK, Prados M, North American Brain Tumor Consortium. PMID: 15514370; PMCID: PMC3820102.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    214. Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. Invest New Drugs. 2004 Nov; 22(4):427-35. Chang SM, Kuhn J, Wen P, Greenberg H, Schiff D, Conrad C, Fink K, Robins HI, Cloughesy T, De Angelis L, Razier J, Hess K, Dancey J, Prados MD, North American Brain Tumor Consortium And The National Cancer Institute. PMID: 15292713.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    215. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):353-7. Chang SM, Lamborn KR, Malec M, Larson D, Wara W, Sneed P, Rabbitt J, Page M, Nicholas MK, Prados MD. PMID: 15380566.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    216. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004 Jul; 6(3):227-35. Lamborn KR, Chang SM, Prados MD. PMID: 15279715; PMCID: PMC1871999.
      View in: PubMed   Mentions: 215     Fields:    Translation:Humans
    217. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer. 2004 Apr 15; 100(8):1712-6. Chang SM, Prados MD, Yung WK, Fine H, Junck L, Greenberg H, Robins HI, Mehta M, Fink KL, Jaeckle KA, Kuhn J, Hess K, Schold C. PMID: 15073861.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    218. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro Oncol. 2004 Apr; 6(2):119-26. Larson DA, Suplica JM, Chang SM, Lamborn KR, McDermott MW, Sneed PK, Prados MD, Wara WM, Nicholas MK, Berger MS. PMID: 15134626; PMCID: PMC1871978.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    219. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1147-52. Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ. PMID: 15001257.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    220. Temozolomide in the treatment of recurrent malignant glioma. Cancer. 2004 Feb 01; 100(3):605-11. Chang SM, Theodosopoulos P, Lamborn K, Malec M, Rabbitt J, Page M, Prados MD. PMID: 14745879.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    221. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Neuro Oncol. 2004 Jan; 6(1):33-7. Prados MD, Yung WK, Fine HA, Greenberg HS, Junck L, Chang SM, Nicholas MK, Robins HI, Mehta MP, Fink KL, Jaeckle KA, Kuhn J, Hess KR, Schold SC, North American Brain Tumor Consortium study. PMID: 14769138; PMCID: PMC1871975.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    222. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg. 2004 Jan; 100(1):41-6. Keles GE, Lamborn KR, Chang SM, Prados MD, Berger MS. PMID: 14743910.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    223. O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas. Neuro Oncol. 2004 Jan; 6(1):28-32. Schold SC, Kokkinakis DM, Chang SM, Berger MS, Hess KR, Schiff D, Robins HI, Mehta MP, Fink KL, Davis RL, Prados MD. PMID: 14769137; PMCID: PMC1871964.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    224. Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol. 2004 Jan; 6(1):44-54. Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, Kuhn J, North American Brain Tumor Consortium study. PMID: 14769140; PMCID: PMC1871968.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    225. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial. J Neurooncol. 2003 Dec; 65(3):269-78. Prados MD, McDermott M, Chang SM, Wilson CB, Fick J, Culver KW, Van Gilder J, Keles GE, Spence A, Berger M. PMID: 14682377.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCellsCTClinical Trials
    226. A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium report. Invest New Drugs. 2003 Nov; 21(4):429-33. Chang SM, Kuhn JG, Ian Robins H, Clifford Schold S, Spence AM, Berger MS, Mehta MP, Pollack I, Gilbert M, Prados MD. PMID: 14586210.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    227. Gliomatosis cerebri: a review of 22 cases. Neurosurgery. 2003 Aug; 53(2):261-71; discussion 271. Vates GE, Chang S, Lamborn KR, Prados M, Berger MS. PMID: 12925240.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    228. Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma. J Neurooncol. 2003 Aug-Sep; 64(1-2):125-37. Weber F, Asher A, Bucholz R, Berger M, Prados M, Chang S, Bruce J, Hall W, Rainov NG, Westphal M, Warnick RE, Rand RW, Floeth F, Rommel F, Pan H, Hingorani VN, Puri RK. PMID: 12952293.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCTClinical Trials
    229. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003 Jul 01; 21(13):2508-18. Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. PMID: 12839017.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCellsCTClinical Trials
    230. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol. 2003 Jun 15; 21(12):2305-11. Jaeckle KA, Hess KR, Yung WK, Greenberg H, Fine H, Schiff D, Pollack IF, Kuhn J, Fink K, Mehta M, Cloughesy T, Nicholas MK, Chang S, Prados M, North American Brain Tumor Consortium. PMID: 12805331.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    231. Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg. 2003 Jun; 98(6):1165-9. Schmidt MH, Berger MS, Lamborn KR, Aldape K, McDermott MW, Prados MD, Chang SM. PMID: 12816258.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    232. Radiation therapy for intracranial germ cell tumors. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):511-8. Haas-Kogan DA, Missett BT, Wara WM, Donaldson SS, Lamborn KR, Prados MD, Fisher PG, Huhn SL, Fisch BM, Berger MS, Le QT. PMID: 12738328.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    233. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro Oncol. 2003 04; 5(2):96-103. Prados MD, Schold SC, Fine HA, Jaeckle K, Hochberg F, Mechtler L, Fetell MR, Phuphanich S, Feun L, Janus TJ, Ford K, Graney W. PMID: 12672281; PMCID: PMC1920676.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCTClinical Trials
    234. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res. 2003 Mar; 9(3):981-90. Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW. PMID: 12631596.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    235. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology. 2003; 65(3):259-66. Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M, Jaeckle KA, Yung WK, Buys SS, Bruner JM, Townsend JJ, Davis R, Sawaya R, Kyritsis AP. PMID: 14657600.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    236. Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1397-404. Larson DA, Prados M, Lamborn KR, Smith V, Sneed PK, Chang S, Nicholas KM, Wara WM, Devriendt D, Kunwar S, Berger M, McDermott MW. PMID: 12459362.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCTClinical Trials
    237. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study. Neuro Oncol. 2002 Apr; 4(2):109-14. Robins HI, Chang SM, Prados MD, Yung WK, Hess K, Schiff D, Greenberg H, Fink K, Nicolas K, Kuhn JG, Cloughesy T, Junck L, Mehta M. PMID: 11916502; PMCID: PMC1920656.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    238. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res. 2002 Jan; 8(1):180-7. Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD. PMID: 11801556.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    239. Age and radiation response in glioblastoma multiforme. Neurosurgery. 2001 Dec; 49(6):1288-97; discussion 1297-8. Barker FG, Chang SM, Larson DA, Sneed PK, Wara WM, Wilson CB, Prados MD. PMID: 11846927.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    240. Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res. 2001 Oct 15; 61(20):7683-8. Kunwar S, Mohapatra G, Bollen A, Lamborn KR, Prados M, Feuerstein BG. PMID: 11606412.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    241. EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):410-8. Barker FG, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, Aldape KD. PMID: 11567815.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCTClinical Trials
    242. Temozolomide in combination with other cytotoxic agents. Semin Oncol. 2001 Aug; 28(4 Suppl 13):24-33. Prados M. PMID: 11550136.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    243. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol. 2001 Apr; 22(4):613-24. Graves EE, Nelson SJ, Vigneron DB, Verhey L, McDermott M, Larson D, Chang S, Prados MD, Dillon WP. PMID: 11290467; PMCID: PMC7976000.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    244. A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report. Cancer. 2001 Jan 15; 91(2):417-22. Chang SM, Kuhn JG, Robins HI, Schold SC, Spence AM, Berger MS, Mehta M, Pollack IF, Rankin C, Prados MD. PMID: 11180089.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    245. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001 Jan 01; 49(1):71-7. Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, Lamborn K, Wilson CB, Phillips TL, Larson DA. PMID: 11163499.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    246. Malignant gliomas. Curr Treat Options Oncol. 2000 Dec; 1(5):459-68. Burton EC, Prados MD. PMID: 12057153.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    247. Biology and treatment of malignant glioma. Semin Oncol. 2000 Jun; 27(3 Suppl 6):1-10. Prados MD, Levin V. PMID: 10866344.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    248. Future directions in the treatment of malignant gliomas with temozolomide. Semin Oncol. 2000 Jun; 27(3 Suppl 6):41-6. Prados MD. PMID: 10866349.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    249. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery. 2000 Feb; 46(2):319-26; discussion 326-8. Graves EE, Nelson SJ, Vigneron DB, Chin C, Verhey L, McDermott M, Larson D, Sneed PK, Chang S, Prados MD, Lamborn K, Dillon WP. PMID: 10690720.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    250. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys. 1999 Dec 01; 45(5):1109-15. Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ. PMID: 10613302.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    251. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol. 1999 Nov; 17(11):3389-95. Prados MD, Scott C, Curran WJ, Nelson DF, Leibel S, Kramer S. PMID: 10550132.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    252. Radiopotentiation of human brain tumor cells by sodium phenylacetate. Cancer Lett. 1999 Aug 03; 142(2):139-46. Ozawa T, Lu RM, Hu LJ, Lamborn KR, Prados MD, Deen DF. PMID: 10463769.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    253. Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome. Clin Cancer Res. 1999 Jun; 5(6):1435-43. Huhn SL, Mohapatra G, Bollen A, Lamborn K, Prados MD, Feuerstein BG. PMID: 10389929.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    254. New chemotherapy options for the treatment of malignant gliomas. Curr Opin Oncol. 1999 May; 11(3):157-61. Burton E, Prados M. PMID: 10328588.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    255. Late radiation injury following hyperfractionated craniospinal radiotherapy for primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys. 1999 Apr 01; 44(1):85-90. Russo C, Fischbein N, Grant E, Prados MD. PMID: 10219799.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    256. Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol. 1999 Mar; 17(3):984-90. Chang SM, Kuhn JG, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Schiff D, Gilbert M, Rankin C, Prados MD. PMID: 10071293.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    257. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients. Cancer. 1999 Feb 15; 85(4):925-35. Lamborn KR, Prados MD, Kaplan SB, Davis RL. PMID: 10091772.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    258. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Int J Radiat Oncol Biol Phys. 1999 Jan 15; 43(2):279-85. Prados MD, Edwards MS, Chang SM, Russo C, Davis R, Rabbitt J, Page M, Lamborn K, Wara WM. PMID: 10030250.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    259. Primary central nervous system tumors: advances in knowledge and treatment. CA Cancer J Clin. 1998 Nov-Dec; 48(6):331-60, 321. Prados MD, Berger MS, Wilson CB. PMID: 9838898.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    260. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol. 1998 Jun; 16(6):2188-94. Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD. PMID: 9626220.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    261. High dose oral tamoxifen and subcutaneous interferon alpha-2a for recurrent glioma. J Neurooncol. 1998 Apr; 37(2):169-76. Chang SM, Barker FG, Huhn SL, Nicholas MK, Page M, Rabbitt J, Prados MD. PMID: 9524096.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    262. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosomes Cancer. 1998 Mar; 21(3):195-206. Mohapatra G, Bollen AW, Kim DH, Lamborn K, Moore DH, Prados MD, Feuerstein BG. PMID: 9523194.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    263. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1998 Feb 01; 40(3):653-9. Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL. PMID: 9486616.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    264. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998 Jan 15; 40(2):287-95. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH. PMID: 9457811.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCTClinical Trials
    265. Chemotherapy of brain tumors. Semin Surg Oncol. 1998 Jan-Feb; 14(1):88-95. Prados MD, Russo C. PMID: 9407635.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    266. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int J Radiat Oncol Biol Phys. 1998 Jan 01; 40(1):57-63. Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB. PMID: 9422558.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    267. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. J Magn Reson Imaging. 1997 Nov-Dec; 7(6):1146-52. Nelson SJ, Huhn S, Vigneron DB, Day MR, Wald LL, Prados M, Chang S, Gutin PH, Sneed PK, Verhey L, Hawkins RA, Dillon WP. PMID: 9400861.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    268. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 1997 Oct; 87(4):525-34. Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, Chang S, Prados MD, Sneed PK, Larson DA, Wara WM, McDermott M, Dillon WP, Gutin PH, Vigneron DB. PMID: 9322843.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansPHPublic Health
    269. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer. 1997 Sep 01; 80(5):936-41. Barker FG, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD. PMID: 9307194.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    270. Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am. 1997 Jul-Aug; 3(4):238-45. Le QT, Weil MD, Wara WM, Lamborn KR, Prados MD, Edwards MS, Gutin PH. PMID: 9263630.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    271. Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys. 1997 May 01; 38(2):257-61. Castro JR, Phillips TL, Prados M, Gutin P, Larson DA, Petti PL, Daftari IK, Collier JM, Lillis-Hearne P. PMID: 9226311.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    272. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol. 1997 May; 32(3):235-41. Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA. PMID: 9049885.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCTClinical Trials
    273. Neuropsychological sequelae of medulloblastoma in adults. Int J Radiat Oncol Biol Phys. 1997 Apr 01; 38(1):21-6. Kramer JH, Crowe AB, Larson DA, Sneed PK, Gutin PH, McDermott MW, Prados MD. PMID: 9211999.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    274. Alignment of volume MR images and high resolution [18F]fluorodeoxyglucose PET images for the evaluation of patients with brain tumors. J Comput Assist Tomogr. 1997 Mar-Apr; 21(2):183-91. Nelson SJ, Day MR, Buffone PJ, Wald LL, Budinger TF, Hawkins R, Dillon WP, Huhn S, Prados MD, Chang S, Vigneron DB. PMID: 9071283.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    275. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer. 1997 Jan 01; 79(1):115-26. Barker FG, Chang SM, Valk PE, Pounds TR, Prados MD. PMID: 8988735.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    276. Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial. Am J Clin Oncol. 1996 Dec; 19(6):609-12. Prados MD, Warnick RE, Mack EE, Chandler KL, Rabbitt J, Page M, Malec M. PMID: 8931682.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    277. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Pediatr Neurosurg. 1996 Oct; 25(4):174-81. Prados MD, Wara W, Edwards MS, Ater J, Rabbit J, Lamborn K, Davis R, Levin VA. PMID: 9293544.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    278. Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors. Pediatr Neurosurg. 1996 Jun; 24(6):314-22. Sneed PK, Russo C, Scharfen CO, Prados MD, Malec MK, Larson DA, Lamborn KR, Lamb SA, Voss B, Weaver KA, Phillips TL, Gutin PH, Wara WM, Edwards MS. PMID: 8988497.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    279. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):37-44. Sneed PK, Lamborn KR, Larson DA, Prados MD, Malec MK, McDermott MW, Weaver KA, Phillips TL, Wara WM, Gutin PH. PMID: 8641924.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    280. Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):803-8. Barker FG, Prados MD, Chang SM, Davis RL, Gutin PH, Lamborn KR, Larson DA, McDermott MW, Sneed PK, Wilson CB. PMID: 8598356.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    281. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg. 1996 Mar; 84(3):442-8. Barker FG, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK, McDermott MW, Sneed PK, Wara WM, Wilson CB. PMID: 8609556.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    282. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg. 1996; 24(1):9-23. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ. PMID: 8817611.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    283. Pineoblastoma in adults. Neurosurgery. 1995 Sep; 37(3):383-90; discussion 390-1. Chang SM, Lillis-Hearne PK, Larson DA, Wara WM, Bollen AW, Prados MD. PMID: 7501100.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    284. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys. 1995 Jul 15; 32(4):1145-52. Prados MD, Warnick RE, Wara WM, Larson DA, Lamborn K, Wilson CB. PMID: 7607936.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    285. Radiation therapy for primary intracranial germ-cell tumors. Int J Radiat Oncol Biol Phys. 1995 Jul 15; 32(4):943-9. Wolden SL, Wara WM, Larson DA, Prados MD, Edwards MS, Sneed PK. PMID: 7607968.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    286. Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet. 1995 Jul 15; 82(2):106-15. Chen P, Iavarone A, Fick J, Edwards M, Prados M, Israel MA. PMID: 7664239.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    287. Fetal dose estimates for radiotherapy of brain tumors during pregnancy. Int J Radiat Oncol Biol Phys. 1995 Jun 15; 32(3):823-30. Sneed PK, Albright NW, Wara WM, Prados MD, Wilson CB. PMID: 7790270.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    288. Chemotherapy for gliomas. Curr Opin Oncol. 1995 May; 7(3):207-13. Chang SM, Prados MD. PMID: 7654821.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    289. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery. 1995 May; 36(5):898-903; discussion 903-4. Sneed PK, Prados MD, McDermott MW, Larson DA, Malec MK, Lamborn KR, Davis RL, Weaver KA, Wara WM, Phillips TL, et al. PMID: 7791979.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    290. The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):85-91. Prados MD, Wara WM, Edwards MS, Larson DA, Lamborn K, Levin VA. PMID: 7619124.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    291. Sarcomas subsequent to cranial irradiation. Neurosurgery. 1995 Apr; 36(4):685-90. Chang SM, Barker FG, Larson DA, Bollen AW, Prados MD. PMID: 7596497.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    292. Infiltrative astrocytomas of the thalamus. J Neurosurg. 1995 Apr; 82(4):548-57. Krouwer HG, Prados MD. PMID: 7897513.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    293. Carboplatin hypersensitivity in children. A report of five patients with brain tumors. Cancer. 1995 Mar 01; 75(5):1171-5. Chang SM, Fryberger S, Crouse V, Tilford D, Prados MD. PMID: 7850717.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    294. Surgery for low-grade glioma: rationale for early intervention. Clin Neurosurg. 1995; 42:383-90. Wilson CB, Prados MD. PMID: 8846605.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    295. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 1994 Oct 15; 30(3):551-6. Wara WM, Le QT, Sneed PK, Larson DA, Prados MD, Levin VA, Edwards MS, Weil MD. PMID: 7928485.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    296. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys. 1994 Jul 01; 29(4):719-27. Sneed PK, Gutin PH, Larson DA, Malec MK, Phillips TL, Prados MD, Scharfen CO, Weaver KA, Wara WM. PMID: 8040017.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    297. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg. 1994 Jul; 81(1):24-30. Mamelak AN, Prados MD, Obana WG, Cogen PH, Edwards MS. PMID: 8207524.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    298. Identical twins with Ollier's disease and intracranial gliomas: case report. Neurosurgery. 1994 May; 34(5):903-6; discussion 906. Chang S, Prados MD. PMID: 8052390.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    299. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: early results of a pilot study. Int J Radiat Oncol Biol Phys. 1994 Jan 15; 28(2):431-8. Prados MD, Wara WM, Edwards MS, Cogen PH. PMID: 8276658.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    300. The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas. J Neurooncol. 1994; 19(2):113-22. Wacker MR, Hoshino T, Ahn DK, Davis RL, Prados MD. PMID: 7964986.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    301. Proliferative potential and prognostic evaluation of low-grade astrocytomas. J Neurooncol. 1994; 19(1):1-9. Ito S, Chandler KL, Prados MD, Lamborn K, Wynne J, Malec MK, Wilson CB, Davis RL, Hoshino T. PMID: 7815099.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    302. A phase II study of intravenous carboplatin for the treatment of recurrent gliomas. J Neurooncol. 1994; 19(1):69-74. Warnick RE, Prados MD, Mack EE, Chandler KL, Doz F, Rabbitt JE, Malec MK. PMID: 7815106.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    303. Gangliogliomas: a clinicopathological study of 25 cases and review of the literature. J Neurooncol. 1993 Aug; 17(2):139-54. Krouwer HG, Davis RL, McDermott MW, Hoshino T, Prados MD. PMID: 8145057.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    304. Long-term survival in patients with glioblastoma multiforme. Neurosurgery. 1993 May; 32(5):716-20; discussion 720. Chandler KL, Prados MD, Malec M, Wilson CB. PMID: 8388081.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    305. Intracranial myxopapillary ependymoma: case report. J Neurooncol. 1993 Mar; 15(3):251-6. Warnick RE, Raisanen J, Adornato BT, Prados MD, Davis RL, Larson DA, Gutin PH. PMID: 8360710.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    306. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer. 1993 Feb 20; 53(4):550-5. Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB. PMID: 8382191.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    307. Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol. 1992 Nov; 14(3):243-53. Mackworth N, Fobair P, Prados MD. PMID: 1460487.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    308. Proliferative characteristics of juvenile pilocytic astrocytomas determined by bromodeoxyuridine labeling. Neurosurgery. 1992 Sep; 31(3):413-8; discussion 419. Ito S, Hoshino T, Shibuya M, Prados MD, Edwards MS, Davis RL. PMID: 1407423.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    309. Cell kinetics of medulloblastomas. Cancer. 1992 Aug 01; 70(3):671-8. Ito S, Hoshino T, Prados MD, Edwards MS. PMID: 1623482.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    310. Diffuse leptomeningeal involvement by a ganglioglioma in a child. Case report. J Neurosurg. 1992 Aug; 77(2):302-6. Wacker MR, Cogen PH, Etzell JE, Daneshvar L, Davis RL, Prados MD. PMID: 1625019.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    311. Proliferative potential and outcome in pediatric astrocytic tumors. J Neurooncol. 1992 Jul; 13(3):277-82. Prados MD, Krouwer HG, Edwards MS, Cogen PH, Davis RL, Hoshino T. PMID: 1325544.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    312. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J Clin Oncol. 1992 May; 10(5):766-71. Levin VA, Prados MD. PMID: 1314890.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    313. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery. 1992 Apr; 30(4):494-7; discussion 497-8. Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, Wilson CB. PMID: 1584346.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    314. A comparison of CT contrast enhancement and BUDR labeling indices in moderately and highly anaplastic astrocytomas of the cerebral hemispheres. Can J Neurol Sci. 1992 Feb; 19(1):34-9. McDermott MW, Krouwer HG, Asai A, Ito S, Hoshino T, Prados MD. PMID: 1562905.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    315. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine. Int J Cancer. 1992 Jan 02; 50(1):1-5. Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson BA, Davis RL, Wilson CB. PMID: 1728598.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    316. Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys. 1992; 23(1):3-8. Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, Davis RL, Ahn DK, Lamborn K, Wilson CB. PMID: 1572829.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    317. Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys. 1992; 23(4):853-61. Sneed PK, Gutin PH, Stauffer PR, Phillips TL, Prados MD, Weaver KA, Suen S, Lamb SA, Ham B, Ahn DK, et al. PMID: 1319981.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    318. Brachytherapy of brain tumors. Stereotact Funct Neurosurg. 1992; 59(1-4):157-65. Sneed PK, Gutin PH, Prados MD, Phillips TL, Weaver KA, Wara WM, Larson DA. PMID: 1338231.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    319. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys. 1992; 24(4):583-91. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, et al. PMID: 1429079.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    320. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience. Int J Radiat Oncol Biol Phys. 1992; 24(4):593-7. Prados MD, Gutin PH, Phillips TL, Wara WM, Sneed PK, Larson DA, Lamb SA, Ham B, Malec MK, Wilson CB. PMID: 1429080.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    321. Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults. Int J Radiat Oncol Biol Phys. 1992; 24(4):599-610. Shrieve DC, Wara WM, Edwards MS, Sneed PK, Prados MD, Cogen PH, Larson DA, Levin VA. PMID: 1429081.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    322. Late manifestations of esthesioneuroblastomas in the central nervous system: report of two cases. Neurosurgery. 1992 Jan; 30(1):93-7. Mack EE, Prados MD, Wilson CB. PMID: 1738462.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    323. Desmoplastic medulloblastoma metastatic to the pancreas: case report. Neurosurgery. 1991 Oct; 29(4):612-6. Krouwer HG, Vollmerhausen J, White J, Prados MD. PMID: 1944847.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    324. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. Int J Radiat Oncol Biol Phys. 1991 Aug; 21(3):709-14. Phillips TL, Levin VA, Ahn DK, Gutin PH, Davis RL, Wilson CB, Prados MD, Wara WM, Flam MS. PMID: 1651306.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    325. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys. 1991 Aug; 21(3):601-6. Gutin PH, Prados MD, Phillips TL, Wara WM, Larson DA, Leibel SA, Sneed PK, Levin VA, Weaver KA, Silver P, et al. PMID: 1651302.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    326. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg. 1991 May; 74(5):701-8. Petronio J, Edwards MS, Prados M, Freyberger S, Rabbitt J, Silver P, Levin VA. PMID: 1901597.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    327. Hyperfractionated irradiation for adults with brainstem gliomas. Int J Radiat Oncol Biol Phys. 1991 Apr; 20(4):757-60. Linstadt DE, Edwards MS, Prados M, Larson DA, Wara WM. PMID: 2004952.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    328. Intradural chordoma of the tentorium cerebelli. Case report. J Neurosurg. 1991 Mar; 74(3):508-11. Warnick RE, Raisanen J, Kaczmar T, Davis RL, Prados MD. PMID: 1993918.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    329. Gemistocytic astrocytomas: a reappraisal. J Neurosurg. 1991 Mar; 74(3):399-406. Krouwer HG, Davis RL, Silver P, Prados M. PMID: 1993905.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    330. Interstitial irradiation and hyperthermia for the treatment of recurrent malignant brain tumors. Neurosurgery. 1991 Feb; 28(2):206-15. Sneed PK, Stauffer PR, Gutin PH, Phillips TL, Suen S, Weaver KA, Lamb SA, Ham B, Prados MD, Larson DA, et al. PMID: 1997888.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    331. Hypothalamic hamartoma associated with Laurence-Moon-Biedl syndrome. Case report and review of the literature. Pediatr Neurosurg. 1991-1992; 17(1):30-3. Diaz LL, Grech KF, Prados MD. PMID: 1811710.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    332. Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas. J Neurooncol. 1990 Apr; 8(2):189-91. Krouwer D, McDermott M, Prados M. PMID: 2358851.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    333. Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. Cancer. 1989 Dec 15; 64(12):2420-3. Rodriguez LA, Prados M, Silver P, Levin VA. PMID: 2555038.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    334. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. J Neurosurg. 1989 Sep; 71(3):335-41. Hoshino T, Prados M, Wilson CB, Cho KG, Lee KS, Davis RL. PMID: 2549222.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    335. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine. Neurosurgery. 1989 Jun; 24(6):806-9. Prados M, Rodriguez L, Chamberlain M, Silver P, Levin V. PMID: 2546093.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    336. Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial. J Neurosurg. 1989 May; 70(5):691-700. Edwards MS, Wara WM, Urtasun RC, Prados M, Levin VA, Fulton D, Wilson CB, Hannigan J, Silver P. PMID: 2709109.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    337. Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia. Cancer Chemother Pharmacol. 1989; 23(5):301-7. Levin VA, Chamberlain M, Silver P, Rodriguez L, Prados M. PMID: 2706735.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    338. A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors. J Neurooncol. 1988 Dec; 6(4):319-23. Chamberlain MC, Prados MD, Silver P, Levin VA. PMID: 3221259.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    339. Treatment of recurrent brain stem gliomas and other central nervous system tumors with 5-fluorouracil, CCNU, hydroxyurea, and 6-mercaptopurine. Neurosurgery. 1988 Apr; 22(4):691-3. Rodriguez LA, Prados M, Fulton D, Edwards MS, Silver P, Levin V. PMID: 3374780.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    340. A phase II trial of oral melphalan in recurrent primary brain tumors. Am J Clin Oncol. 1988 Feb; 11(1):52-4. Chamberlain MC, Prados MD, Silver P, Levin VA. PMID: 2829615.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    341. Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas. Cancer Treat Rep. 1987 Nov; 71(11):1105-6. Prados M, Rodriguez L, Seager M, Silver P, Levin V. PMID: 3119204.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    342. Malignant supratentorial gliomas in childhood. Pediatr Neurosci. 1987; 13(3):144-51. Prados M, Levin V. PMID: 3331428.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    343. Current management of brain stem gliomas. Pediatr Neurosci. 1987; 13(6):309-15. Edwards MS, Prados M. PMID: 3332719.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Michael's Networks
    Concepts (740)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (119)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.